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Abstract 
Age-related macular degeneration (AMD) is an irreversible, degenerative condition 
and the major cause of debilitating central vision loss in adults over 50 years. The 
loss of visual acuity is from damage and ultimate death of the image-forming rod and 
cone photoreceptors. Rods and cones are differentially affected in AMD with rods 
affected first and while conventional tests administered under rod-mediated scotopic 
(dark) illumination are highly sensitive to retinal deficits in early AMD, they are 
time-consuming. Even though tests administered under cone-mediated photopic 
(bright) illumination may be less sensitive to early defects, the initial loss of rods 
may affect cone function. When measured under mesopic (dim) illumination where 
both rods and cones are active, retinal deficits may be enhanced, providing the means 
for early detection of retinal dysfunction in AMD before the disease is clinically 
manifest. Progression of the disease ultimately affects the retinal ganglion cells, 
however it is unknown how AMD affects intrinsically photosensitive retinal ganglion 
cells (ipRGCs), a sub-class of ganglion cells expressing the melanopsin 
photopigment which have both image-forming and non-image forming functions. 
These ipRGCs project to multiple brain centres including the suprachiasmatic 
nucleus (SCN) responsible for circadian regulation and the olivary pretectal nucleus 
(OPN) which mediates the pupil response. Therefore, AMD affected ipRGCs may 
cause aberrant signalling to the SCN and OPN and may contribute to sleep 
disturbances and depression in AMD. 
 
This thesis investigated the use of commercially available ophthalmic tests 
administered under reduced (mesopic) illumination for detection of early retinal 
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deficits in AMD (Experiment 1). Pupillometry was used to measure ipRGC function 
in early AMD (Experiment 2) and the effect of inner retinal ipRGC dysfunction on 
sleep and depression in late AMD (Experiment 3).  
 
In Experiment 1 (Chapter 4), image-forming function was measured using the Pelli-
Robson contrast sensitivity (CS) chart and MP-1 microperimeter under low mesopic 
compared to standard illumination in healthy participants and in patients with AMD 
(AREDS Grade 2/3). Mesopic Pelli-Robson CS detected functional deficits before 
photopic CS in early and intermediate AMD that could be differentiated from normal 
ageing while low mesopic microperimetry did not further increase sensitivity to 
retinal deficits in AMD. In Experiment 2 (Chapter 5), the pupil light reflex (PLR) 
was measured in early AMD patients and age-matched controls using a custom-built 
Maxwellian-view pupillometer with sinusoidal stimuli of high melanopsin excitation 
for ipRGC activation and low melanopsin excitation that biased activation to the 
outer retina. The melanopsin controlled Post-Illumination Pupil Response (PIPR), the 
sustained redilation after light offset, was dysfunctional in the AMD patients, 
providing the initial report of ipRGC deficits in early and intermediate AMD. 
Experiment 3 (Chapter 6) evaluated ipRGC function using pupillometry and 
determined its relationship with sleep quality and presence of depression in patients 
with advanced AMD. A significant correlation between ipRGC dysfunction and 
reduced sleep efficiency identified a retinal contribution to sleep disorders in AMD.    
  
The results of these experiments show that a mesopic measure of contrast sensitivity 
provides an easily administered clinical test that may identify susceptibility to AMD 
before the disease is manifest, and before it is detectable under standard photopic 
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administered conditions. This research provides the initial report that the melanopsin 
controlled PIPR is dysfunctional in early AMD and validates pupillometry as a non-
invasive, objective measurement of ipRGC function in early AMD. Finally, an 
association between ipRGC dysfunction and the observed reduction in sleep 
efficiency in advanced AMD was identified. 
 
In conclusion, this thesis proposes new clinical protocols for the early detection of 
retinal deficits in AMD and provides insight into the effect of AMD on inner retinal 
function, extending to both image-forming and non-image forming functions.  
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 Introduction Chapter 1:
Age-related macular degeneration (AMD) is a complex disease of the central 
retina and one of the most challenging to determine in terms of its aetiology and 
pathomechanisms. A number of risk factors have been implicated in its pathogenesis, 
including genetic predisposition (de Jong, Bergen, Klaver, van Duijn & Assink 2001; 
Edwards et al. 2005; Rivera et al. 2005; Smailhodzic et al. 2012), environmental 
factors (Khan et al. 2006; Seddon et al. 2001; Smith, Mitchell & Leeder 1996) and 
advancing age (Beatty, Koh, Phil, Henson & Boulton 2000; Pauleikhoff, Harper, 
Marshall & Bird 1990; Smith et al. 2001).   
Traditionally, research has focussed on the effect of AMD within the retinal layers, 
with vision loss attributed to retinal pigment epithelium (RPE) dysfunction and 
consequent photoreceptor death (Dunaief, Dentchev, Ying & Milam 2002; Maeda et 
al. 1998). This occurs in response to deposition of cellular debris in the outer retina 
between Bruch’s membrane (BM) and the RPE (Holz, Pauleikhoff, Klein & Bird 
2004; Sarks 1976), ultimately leading to geographic atrophy (GA; dry AMD) or 
choroidal neovascularization (CNV; wet AMD). Rod photoreceptors are affected 
first with maximum loss parafoveally (Curcio, Medeiros & Millican 1996; Curcio, 
Owsley & Jackson 2000; Owsley et al. 2000) and subsequent cone photoreceptor loss 
with disease progression.  
In addition to rod and cone loss, the inner retina is affected with a loss of ganglion 
cells in advanced stages of AMD (Medeiros & Curcio 2001). Intrinsically 
photosensitive retinal ganglion cells (ipRGCs) (Berson 2003; Berson, Dunn & Takao 
2002; Dacey et al. 2005) are a specific group of melanopsin expressing ganglion 
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cells with cell bodies in the ganglion cell layer (GCL) and dendrites that stratify in 
the sublaminae of the inner plexiform layer (IPL) (Dacey et al. 2005) (Figure 1.1). At 
least five ipRGC subtypes (M1-M5) have been identified in animal models (Schmidt 
et al. 2011b) however only M1 and M2 subtypes have been identified in humans and 
primates (Jusuf, Lee, Hannibal & Grünert 2007; Liao et al. 2016) (Figure 1.1). 
IpRGCs receive intrinsic and extrinsic input and project irradiance information to 
multiple brain centres (Berson et al. 2002; Dacey et al. 2005; Hattar, Liao, Takao, 
Berson & Yau 2002). While their involvement in AMD is currently not fully 
understood, pilot data indicate that they are dysfunctional in late stages of the 
condition (Feigl & Zele 2014). Whether they are affected in early AMD as has been 
shown for glaucoma (Adhikari, Zele, Thomas & Feigl 2016b) and in diabetes 
without retinopathy (Feigl et al. 2012b) is yet to be determined. 
 
Figure 1.1: Retinal layers and brain centre projections of rod and cone photoreceptors 
and ipRGCs   
The choroid lies posterior to the retina and is separated from the retinal pigment epithelium 
(RPE) by Bruch’s membrane (BM). The outer retina (including the RPE and rod and cone 
photoreceptors) transitions to the inner retina between the outer plexiform and inner nuclear 
layers (horizontal dashed line). The inner retina includes the conventional ganglion cells 
(RGC) and melanopsin expressing ganglion cells (M1 and M2 in humans and primates) with 
dendrites that stratify in the inner plexiform layer (IPL) and which project to various centres 
in the brain that regulate image-forming functions (vision; green line) and non-image-
forming functions (sleep, mood and pupil; brown lines).  
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The discovery of ipRGCs has initiated research into understanding their 
contributions to image and non-image forming centres in the brain, facilitating 
measurement of the effects of AMD beyond the retina (Figure 1.1). Retinal 
projections to the visual cortex provide a means to measure image-forming function 
through clinically administered vision function tests. These tests differentiate 
between rods and cones under either scotopic (dark) or photopic (bright) illumination 
and while rods may be sensitive to early loss in AMD, rod-mediated scotopic tests 
require a period of dark adaptation and are therefore time-consuming and not 
practical for use in clinical practice. Shared post-receptoral pathways and a paracrine 
relationship suggest an interaction between rod and cone signals under mesopic 
illumination where both rods and cones are active, therefore early rod deficits may 
affect cone function. This suggests that tests administered under mesopic 
illumination may be more sensitive to retinal deficits in AMD. With no current cure 
for AMD, the prognosis for maximum retention of central vision is better with early 
detection and management of the disease. Experiment 1 (Chapter 4) measured retinal 
function under mesopic illumination by modifying clinically available tests and 
enabled early detection of outer retinal deficits associated with the disease that could 
be differentiated from normal ageing. 
With projections to the olivary pretectal nucleus (OPN) that mediate the pupil light 
reflex (PLR) (Gamlin et al. 2007; Lucas, Douglas & Foster 2001a; Markwell, Feigl 
& Zele 2010; McDougal & Gamlin 2010), ipRGC function can be measured in vivo. 
Due to the expression of melanopsin with a peak spectral sensitivity of 482 nm 
(Dacey et al. 2005), ipRGCs produce a sustained pupil response after offset of short 
wavelength stimuli, the post-illumination pupil response (PIPR) (Gamlin et al. 2007; 
Markwell et al. 2010), which is absent with presentation of long-wavelength stimuli. 
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Experiment 2 (Chapter 5) used pupillometry (section 3.2.2) to measure ipRGCs in 
patients with early and intermediate AMD and provided the first evidence of inner 
retinal dysfunction at early stages of disease.  
IpRGC projections to other brain centres include regulation of circadian rhythm 
(Berson et al. 2002; Hattar et al. 2002; Panda et al. 2002) and mood (LeGates et al. 
2012), therefore the effect of AMD on ipRGC function may have consequences 
beyond vision loss. Studies in melanopsin knock-out mice show sleep disturbances 
where they sleep for approximately one hour less than wild-type mice (Tsai et al. 
2009) while human studies show that ipRGC deficits are associated with sleep 
disorders in glaucoma (Gracitelli et al. 2015) and their function is reduced in 
seasonal affective disorder (Roecklein et al. 2013). With the high prevalence of 
depression in AMD (Brody et al. 2001; Casten & Rovner 2013) and altered sleep 
duration that is dependent on AMD type (wet or dry) (Khurana et al. 2016; Pérez-
Canales, Rico-Sergado & Pérez-Santonja 2016), ipRGC dysfunction in AMD may 
contribute to these disorders. Experiment 3 (Chapter 6) determined the relationship 
between ipRGC function and sleep or depression disorders and demonstrated that 
ipRGCs contribute to reduced sleep efficacy in advanced stages of AMD.  
The aim of this thesis was to provide new and novel approaches to measuring outer 
(image forming) and inner (non-image forming) retinal function in early AMD to 
facilitate early detection and monitoring of the disease. Also, by determining the 
association of ipRGC function with sleep and mood, we have contributed to a better 
understanding of how advanced AMD affects non-image forming functions. 
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 Literature Review Chapter 2:
This chapter critically reviews the literature on age-related macular degeneration 
(AMD) with a focus on current measures of outer and inner retinal function in AMD. 
The effect of retinal dysfunction on non-image forming functions is discussed and 
research gaps are identified. The chapter concludes with the thesis rationale, 
experimental aims and hypotheses.   
 EARLY AND ADVANCED AGE-RELATED MACULAR 2.1
DEGENERATION 
2.1.1 Background 
Age-related macular degeneration (AMD) is a degenerative and progressive 
disease of the central retina and a leading cause of severe visual impairment in 
persons older than 55 years (Attebo, Mitchell & Smith 1996; Mitchell, Smith, Attebo 
& Wang 1995). The macula covers the central 14 degrees of the retina and contains 
the highest density of rod and cone photoreceptors (Curcio, Sloan, Kalina & 
Hendrickson 1990) and intrinsically photosensitive retinal ganglion cells (ipRGCs), a 
small subset of the retinal ganglion cell population (Berson et al. 2002; Dacey et al. 
2005). In advanced AMD, a loss of central vision results from disruption and death 
of the photoreceptors and the underlying layers (retinal pigment epithelium, Bruch’s 
membrane and choriocapillaris) due to central geographic atrophy (GA) or from 
subretinal choroidal neovascularization (CNV). Pathophysiologically, these two 
advanced forms of AMD are distinct (Seddon & Chen 2004) and the susceptibility to 
either GA or CNV might be driven by different gene polymorphisms (Sobrin et al. 
2011). The progression of AMD occurs in response to deposition of cell debris 
containing proteins related to inflammation, so-called drusen (Figure 2.1), between 
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the retinal pigment epithelium (RPE) and Bruch’s membrane (BM) at early stages of 
disease (Sarks, Sarks & Killingsworth 1994).  
 
Figure 2.1: Visual representation of drusen  
Panel A shows the retina of a participant’s left eye with early AMD and the presence of 
drusen (yellow deposits) while Panel B shows a stain of drusen between the retinal pigment 
epithelium (RPE) and Bruch’s membrane (BM). [Panel B modified from Donoso et al, 
(2006)]  
 
 
Early AMD is characterized by increased pigmentary changes and/or depigmentation 
of the RPE, as well as by drusen > 63 µm in diameter (Figure 2.1A and B) (Bird et 
al. 1995). As drusen increase in size and number, they may cause a distortion in 
vision, affecting colour contrast sensitivity (Frennesson, Nilsson & Nilsson 1995) 
and central visual field sensitivity (Midena, Segato, Blarzino & Degli Angeli 1994). 
Late or advanced AMD is further divided into dry and wet AMD (For a review see 
Ambati, Ambati, Yoo, Ianchulev & Adamis 2003). Dry AMD, also known as 
geographic atrophy, is caused by slow, progressive atrophy of the photoreceptors, 
RPE and choriocapillaris. Geographic atrophy is characterized by a sharply 
demarcated area of at least 175 μm in diameter of hypopigmentation, depigmentation 
or apparent absence of the RPE in the macular area (Figure 2.2A). Large choroidal 
vessels in this area are more visible than in surrounding areas (Bird et al. 1995), 
differentiating geographic atrophy from hypopigmentation of the RPE found in other 
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ocular pathologies such as macular dystrophy (O'Donnell & Welch 1979). Patients 
may experience initial blind spots in their central vision which progress slowly to 
complete central vision loss in the advanced stages over approximately 5 years 
(Sarks, Sarks & Killingsworth 1988).  
 
Figure 2.2: Visual representation of AMD 
Panel A is the retina of a left eye with advanced geographic atrophy. An area of 
depigmentation and absence of RPE with visible choroidal vessels is seen in the macula 
region. Panel B is the retina of a left eye with choroidal neovascularization. Blood and serum 
leakage below the retina around the macula is evident. Photographs are from participants in 
this study. 
 
Wet AMD, also known as neovascular or exudative AMD, is caused by choroidal 
neovascularization (CNV) which is the growth of new blood vessels from the 
choroid through defects in Bruch’s membrane. The exact mechanism behind the 
growth of these vessels is unknown, however evidence suggests an imbalance in 
growth factors plays a role (Schlingemann 2004). In a normal eye, vascular 
endothelial growth factor (VEGF) is secreted by the RPE to support angiogenesis 
(Witmer, Vrensen, Van Noorden & Schlingemann 2003) while the pigment 
epithelium derived factor (PEDF) is an angiogenic inhibitor believed to be essential 
for maintaining homeostasis (Stellmach, Crawford, Zhou & Bouck 2001). An 
increase in VEGF expression (Kliffen, Sharma, Mooy, Kerkvliet & de Jong 1997) 
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and decrease in PEDF (Holekamp, Bouck & Volpert 2002) is evident in AMD, 
enhancing the abnormal growth of blood vessels from the choroid. Initial signs of 
CNV is often subretinal or sub-RPE haemorrhage (Figure 2.2B). Left untreated, 
CNV can lead to blindness in one eye within several months while the risk of the 
fellow eye developing wet AMD within five years ranges from 7% for patients with 
no signs of drusen or hyperpigmentation in that eye to 87% for patients with more 
than five drusen, macular hyperpigmentation and systemic hypertension (Macular 
Photocoagulation Study Group 1997).  
 
In an effort to standardise definitions and unify different stages of AMD, various 
grading systems were introduced (Age-Related Eye Disease Study Research Group 
2001b, 2005; Bird et al. 1995; Ferris et al. 2013; Klein et al. 1991; Seddon, Sharma 
& Adelman 2006). The Wisconsin ARM grading system developed a method of 
grading ARM from fundus photographs based on drusen size and pigmentation 
(Klein et al. 1991), however the system is complex and not easily administered. The 
ARM epidemiological study group introduced stereoscopic fundus transparencies to 
detect and define AMD, however specific fundus image sizes are required and 
extensive training with experienced graders is important when using this grading 
system (Bird et al. 1995). Ferris et al (2013), on behalf of the Beckman initiative for 
macular research classification committee, developed a 5-stage classification scale 
that differentiates normal ageing changes from early AMD and has value in 
predicting risk of AMD progression (Ferris et al. 2013) although their focus was on 
identifying AMD phenotypes. The clinical age-related maculopathy staging 
(CARMS) system divides patients into five mutually exclusive categories based on 
slit-lamp assessment and provides a feasible means for grading in clinical practices 
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without fundus cameras as well as a practical method for grading fundus photographs 
in research (Seddon et al. 2006). A grading system developed by the AREDS group 
modified the Wisconsin grading system to detect change in AMD status (Age-
Related Eye Disease Study Research Group 2001b). This is a comprehensive grading 
scale and has value in research, although it is complex for clinical use. The most 
common grading system currently used is the simplified AREDS severity scale (Age-
Related Eye Disease Study Research Group 2005) which defines risk categories for 
development of advanced AMD that can be determined by clinical examination or 
photographic procedures that are less demanding than the original AREDS scale. The 
grading systems were introduced to detect onset of AMD, to determine the risk of 
disease progression and to monitor progression of AMD. This study used the 
AREDS scale (Age-Related Eye Disease Study Research Group 2001b) (Table 2.1) 
to identify and grade severity of AMD. 
Table 2.1: AREDS age-related macular degeneration grading levels  
AMD 
Level 
Criteria 
1 Drusen maximum size < circle C-0 (63 μm diameter) and total area < circle C-1 (125 μm diameter) 
2 Presence of one or more of the following:  
a) Drusen maximum size ≥ circle C-0 but < circle C-1 
b) Drusen total area ≥ circle C-1 
c) RPE pigment abnormalities consistent with AMD, defined as one or more of the following in 
the central or inner subfields 
1. Depigmentation present 
2. Increased pigment ≥ circle C-1 
3. Increased pigment present and depigmentation at least questionable 
3 Presence of one or more of the following: 
a) Drusen maximum size ≥ circle C-1 
b) Drusen maximum size ≥ circle C-0 and total area > circle I-2 and type is soft indistinct 
c) Drusen maximum size ≥ circle C-0 and total area > circle O-2 and type is soft distinct 
d) Geographic atrophy within grid but none at centre of macula 
4 Presence of one or more of the following: 
a) Geographic atrophy in central subfield with at least questionable involvement of center of 
macula 
b) Evidence of neovascular AMD 
1. Fibrovascular/serous pigment epithelial detachment 
2. Serous (or hemorrhagic) sensory retinal detachment 
3. Subretinal/subretinal pigment epithelial haemorrhage 
4. Subretinal fibrous tissue (or fibrin) 
5. Photocoagulation for AMD 
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2.1.2 Risk of AMD progression  
Population-based studies have reported on the prevalence and incidence of AMD 
around the world. The Beaver Dam study showed a 24% prevalence of intermediate 
large, soft drusen ≥125 μm in persons 75 years or older (Klein, Klein & Linton 1992) 
with 14% of eyes with drusen developing advanced AMD over ten years (Klein, 
Klein, Tomany, Meuer & Huang 2002). In Australia, the Blue Mountains study 
showed the presence of soft drusen to be associated with an 18.5% increased risk of 
progression to advanced AMD in persons 85 years or older (Mitchell et al. 1995; 
Wang, Foran, Smith & Mitchell 2003). In the Rotterdam study, the incidence of 
AMD was again strongly dependent on age although incidence was lower than in the 
Beaver Dam and Blue Mountains Studies (Klaver et al. 2001). In a study by Sarraf et 
al (1999), persons with drusen in the fellow eye of unilateral exudative AMD have a 
higher risk of developing CNV within four years, as well as an increased incidence 
of geographical atrophy thereafter (Sarraf et al. 1999). Also, persons with bilateral 
drusen and good vision have an increased risk of atrophic lesions of 8% over three 
years (Holz et al. 1994). Studies by the Macular Photocoagulation Group show that 
over five years, 62% of eyes with extrafoveal CNV and 65% of eyes with juxtafoveal 
CNV suffer severe vision loss (Macular Photocoagulation Study Group 1994). In 
persons with unilateral CNV, legal blindness in the fellow eye is 12% over five years 
(Macular Photocoagulation Study Group 1997).  
 
Approximately 1 in 7 Australians over the age of 50 (in the order of 1.2 million 
people) have some evidence of AMD. This number is expected to increase by 70% to 
1.7 million by 2030 without effective intervention. AMD is increasingly becoming a 
burden to the ageing population and the health system with the total cost of vision 
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loss associated with AMD estimated at around $5 billion in 2010 (Deloitte Access 
Economics & Macular Degeneration Foundation 2011). There is an obvious need for 
early detection to optimise treatment intervention and thus reduce the risk of vision 
loss from macular degeneration in Australia.  
 
Despite intensive research into the aetiology of AMD, the pathomechanisms are still 
to be determined (For a review see Feigl 2009). A combination of genetic, 
environmental and lifestyle risk factors have been linked to the onset of AMD which 
are discussed in the following section. 
 
2.1.3 Aetiology 
Genetics 
Several gene variants, or single nucleotide polymorphisms (SNPs), have been 
associated with AMD, the most strongly associated being the Complement Factor H 
gene (CFH Y402; rs1061170), a major regulator of the complement system (Edwards 
et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005). The 
complement system is composed of proteins that are activated through enzymatic 
cleavage in response to inflammation and perform an essential role in eliminating 
damaged cells (For a review see Gehrs, Jackson, Brown, Allikmets & Hageman 
2010). AMD has been hypothesized to result from changes in CFH protein levels, 
reducing the ability of CFH to regulate the complement system and leading to 
increased inflammatory response within the macula. Drusen are the hallmark 
deposits associated with local inflammation and aberrant complement activation in 
AMD, which consist of extracellular material from the RPE and activated 
complement complex (C5b-9) proteins (Anderson, Mullins, Hageman & Johnson 
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2002; Hageman et al. 2001). Aberrant complement activation has been linked not 
only with high risk alleles in CFH (C allele) but also with the Age-Related 
Maculopathy Susceptibility 2 gene (ARMS2; rs10490924; T allele) (Smailhodzic et 
al. 2012), although its function is unclear. Persons with both CFH and ARMS2 gene 
variants are 50% more at risk for developing AMD (Rivera et al. 2005; Schaumberg, 
Hankinson, Guo, Rimm & Hunter 2007). Feigl et al (2012a) showed altered 
neuroretinal activity in middle-aged healthy high risk AMD genotypes compared to 
age-matched healthy low risk AMD genotypes with no signs of AMD, indicating 
possible early inflammatory responses that precede clinical visible changes in 
persons at high risk of developing the disease. This may have implications for early 
detection of AMD as high risk genotypes may have retinal deficits that are not 
identified with current clinical testing techniques until the disease is manifest. 
 
Twin and family studies have indicated AMD to be hereditary, with a genetic 
contribution in up to 25% of cases (Age-Related Eye Disease Study Research Group 
2000) and immediate relatives of an AMD patient being three times more likely to 
develop exudative AMD (Klaver et al. 1998). An English twin study estimated 
overall inheritability to be 45% (Hammond et al. 2002) while sibling analysis has 
shown that up to 57% of AMD hereditary variability can be attributed to single gene 
segregation (Heiba, Elston, Klein & Klein 1994). It is hypothesized that an 
underlying genetic factor correlated with light iris colour may be associated with 
AMD risk, however this has not been confirmed (Mitchell, Smith & Wang 1998). 
Darker iris colour has been correlated with a more densely pigmented choroid which 
provides the retina with a protective mechanism against light damage, therefore 
patients with lighter iris colour are at greater risk of developing AMD, possibly due 
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to less protective pigmentation (Weiter, Delori, Wing & Fitch 1985; Young 1988). It 
is clear that there is a major genetic contribution to the development of AMD 
although no single gene has been identified as a significant contributor to the onset of 
AMD. Feigl et al (2011a) have related AMD high risk genotypes with reduced 
mesopic critical fusion frequency using specialised equipment, introducing mesopic 
vision as a biomarker to document subclinical retinal changes in risk genotypes. This 
thesis aimed to determine retinal function in healthy high and low risk genotypes 
using commercially available and easily administered tests in order to detect AMD 
before it is clinically manifest, allowing control of extraneous lifestyle factors where 
possible. 
 
Age 
Advanced age is a major risk factor in AMD progression (Evans 2001; Smith et 
al. 2001; van Leeuwen, Klaver, Vingerling, Hofman & de Jong 2003) with 
neovascular AMD or geographic atrophy rare under the age of 55 years, becoming 
more prevalent in persons over 75 years (Friedman et al. 2004; Klein et al. 1992). 
The ageing process is associated with physiological and anatomical changes in the 
eye and due to its high consumption of oxygen, the retina is particularly susceptible 
to ischemia and oxidative stress (For a review see Feigl 2009). Ageing is further 
associated with biological changes in the eye such as progressive accumulation of 
lipids and thickening of Bruch's membrane (Guymer, Luthert & Bird 1999) which is 
implicated in photoreceptor dysfunction and pigment epithelial detachment 
(Pauleikhoff et al. 1990). With increasing age, antioxidant levels decrease and the 
formation of free radicals (reactive oxygen intermediates; ROI) increases, causing an 
imbalance in the oxidant-antioxidant ratio which contributes to the pathogenesis of 
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disease (Beatty et al. 2000; Jarrett & Boulton 2012), although the role of oxidative 
stress in the pathogenesis of AMD is unproven. Age-associated increased ischemia 
and oxidative stress, together with AMD risk gene variants may also play a role in 
the manifestation of AMD (Feigl 2009). 
 
Environmental risk 
Smoking is well established as the strongest environmental risk associated with 
AMD development in both prior and current smokers (Khan et al. 2006; Smith et al. 
1996) with evidence of increased risk of developing AMD at a substantially earlier 
age in current smokers compared to past smokers or those who have never smoked 
(Mitchell, Wang, Smith & Leeder 2002). It is hypothesized that smoking affects a 
number of metabolic processes associated with AMD including reduction in 
choroidal blood flow leading to ischemia (Grunwald, Metelitsina, DuPont, Ying & 
Maguire 2005), lowering of antioxidant levels (Beatty et al. 2000), immune 
activation and reduction of macular carotenoid pigments (Hammond, Wooten & 
Snodderly 1996).  
 
The role of sunlight exposure has conflicting reports of being a potential risk in 
development of AMD (Cruickshanks, Klein & Klein 1993; Sui et al. 2013). The 
cornea and lens absorb damaging ultraviolet light and while macular pigment is 
thought to protect the macula by absorbing transmitted blue light, intense blue light 
exposure induces retinal damage (Algvere, Marshall & Seregard 2006; Margrain, 
Boulton, Marshall & Sliney 2004) and may be related to onset of AMD (Taylor et al. 
1992). A systematic review and meta-analysis of 14 studies using the pooled odds 
ratio (OR) and corresponding 95% confidence interval (CI) identified an association 
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between sunlight exposure and increased risk of AMD (Sui et al. 2013), concluding 
that sunlight is proven as a risk factor.  
 
Further risk factors for AMD include high dietary vegetable fat intake (Cho et al. 
2001; Seddon et al. 2001; Smith, Mitchell & Leeder 2000) which is associated with 
an elevated risk of developing CNV (Cho et al. 2001; Seddon et al. 2001). The intake 
of omega-3 however, reduced the risk of AMD (Seddon et al. 2001). Hypertension 
(Mares-Perlman et al. 1995; Smith et al. 2000), low dietary intake of antioxidants 
(Age-Related Eye Disease Study Research Group 2001c) and alcohol consumption 
(Evans 2001) also play an important role in the development and progression of 
AMD.  
2.1.4 Treatment 
There is currently no cure for advanced AMD although several treatment options 
have been developed. Previous gold standard of treatment included laser 
photocoagulation and photodynamic therapy (PDT) (Schmidt-Erfurth & Hasan 2000; 
Treatment of age-related macular degeneration with photodynamic therapy (TAP) 
Study Group 1999; Wu & Murphy 1999), however, high recurrence of CNV 
remained a challenge and these treatments failed to stop the progression of advanced 
AMD. The identification and role of vascular endothelial growth factor-A (VEGF-A) 
in the occurrence of ocular neovascularization led to the development of intravitreal 
anti-VEGF drugs that are now established treatments of AMD (Brown et al. 2006; 
Landa et al. 2009; Rosenfeld et al. 2006; Subramanian et al. 2009). Two of these 
drugs, Ranibizumab (Lucentis®) and Aflibercept (Eylea®), were designed 
specifically for the treatment of AMD. A third drug, Bevacizumab (Avastin®), was 
originally developed to treat colon cancer, but its ability to significantly reduce blood 
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vessel growth facilitated its use "off-label" in AMD patients. Avastin is a humanized 
monoclonal antibody to VEGF (Hurwitz et al. 2004) while Lucentis is an antibody 
binding site fragment that penetrates the retina better and has a higher affinity to 
VEGF-A (Bakri et al. 2007). Eylea binds to VEGF-A and acts as a decoy to inhibit 
binding and activation of VEGF receptors (Frampton 2012). While all three drugs 
have high efficacy and excellent outcomes, Eylea is currently the preferred drug in a 
number of clinics as less frequent injections are required (Lanzetta, Mitchell, Wolf & 
Veritti 2013), although a recent one-year clinical analysis suggests that Eylea and 
Lucentis are equivalent in terms of injection frequency and visual outcomes (Böhni 
et al. 2015). As with any treatment, prognosis improves with earlier detection, 
reinforcing the need to develop early detection techniques.  
 
The ability to screen patients at a preclinical stage before AMD is manifest allows 
for lifestyle changes; including healthy diet, antioxidant supplements, physical 
exercise and not smoking (Mares et al. 2011), hence the possibility to delay or 
prevent AMD progression. The use of oral antioxidants; including vitamin E, vitamin 
C, beta carotene, zinc and copper (AREDS formula) in AMD treatment reduced 
progression from intermediate AMD (≤ 125 µm sized drusen) to advanced AMD by 
about 25% in a large clinical trial (Age-Related Eye Disease Study Research Group 
2001c; Klein et al. 2008). A recent follow up study that supplemented macular 
carotenoids lutein + zeaxanthin (L+Z), in addition to the AREDS formula, showed a 
further ~10% reduction in the progression of early to intermediate AMD, however 
there was no significant effect of antioxidants on advanced AMD (GA and CNV) 
(Age-Related Eye Disease Study 2 Research Group 2013). 
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Overall, the treatment of AMD remains challenging. Research over the last decade 
has focussed on the measurement of outer retina (rod and cone photoreceptor) 
function changes in AMD with the central aim to develop new methods for detection 
of early AMD. The discovery of a new subset of retinal cells, intrinsically 
photosensitive retinal ganglion cells (ipRGCs) (Berson et al. 2002) has provided the 
means to further our knowledge of how AMD affects the inner retina. The effect of 
AMD on rods, cones and ipRGCs and current methods of testing will be briefly 
reviewed in the following sections.  
 
 RETINAL FUNCTION IN AMD 2.2
2.2.1 Rod and cone photoreceptor function 
The RPE plays an important role in supporting the metabolically active 
photoreceptor layer and maintaining the integrity of the blood-retinal barrier (Rizzolo 
1997). It has been proposed that chronic choroidal ischemia causes the deposition of 
sub RPE drusen that in turn leads to inflammation and together with an inappropriate 
immune activation due to gene variations, detrimentally affects their ability to 
remove dead or dying retinal cells (For a review see Feigl 2009). Vision loss 
associated with AMD is due to dysfunction and death of the rod and cone 
photoreceptors secondary to RPE degeneration (Sarks 1976).  
 
Retinal function is compromised before central visual acuity (For a review see 
Lovie-Kitchin & Feigl 2005) as AMD develops parafoveally (Cheng & Vingrys 
1993; Swann & Lovie-Kitchin 1991), beginning inferior and forming an annulus 
(Curcio, Millican, Allen & Kalina 1993). Also, the loss of rods precedes cone loss in 
75% of cases with maximum loss parafoveally (1-3mm from fovea) (Curcio et al. 
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1996; Curcio et al. 2000). In the remaining 25% of AMD cases, cone precedes rod 
degeneration, although this is unexplained (Jackson, Owsley & Curcio 2002). 
Finally, pigmentary changes and distribution of soft drusen increase at parafoveal 
locations (Wang et al. 1996). This has led to a number of psychophysical and 
electrophysiological studies investigating focal retinal function in normal ageing, 
early and advanced AMD under cone-mediated photopic, rod-mediated scotopic and 
cone/rod-mediated mesopic illumination (Feigl, Brown, Lovie-Kitchin & Swann 
2004, 2005b, 2006; Mayer, Spiegler, Ward, Glucs & Kim 1992; Owsley et al. 2000; 
Sandberg, Miller & Gaudio 1993; Sunness et al. 1997).  
 
2.2.2 Intrinsically photosensitive retinal ganglion cell function 
Intrinsically photosensitive retinal ganglion cells (ipRGCs) form a recently 
identified class of retinal ganglion cells responsible for signalling light information 
for non-image-forming functions (Do & Yau 2010; Hattar et al. 2002; Markwell et 
al. 2010), including regulation of circadian rhythm (Berson et al. 2002; Hattar et al. 
2002; Panda et al. 2002), mediation of the pupil light reflex (Gamlin et al. 2007; 
Lucas et al. 2001a; Markwell et al. 2010), and mood (LeGates et al. 2012). While 
AMD affects outer (rod and cone) retinal layers in the early stages of the disease, 
progressing to the inner retina with ~50% loss of ganglion cells in advanced stages 
(Medeiros & Curcio 2001), initial functional changes in AMD that occur in the 
paracentral region (Swann & Lovie-Kitchin 1991) where the highest distribution of 
ipRGCs is found (Dacey et al. 2005) may cause ipRGC dysfunction in early AMD 
(Feigl & Zele 2014). With a population of ~3000, these cells represent only a small 
subset (0.2%) of the total retinal ganglion cell population but have giant-sized soma 
and the largest identified dendritic fields (~ 400-1200 μm) compared to midget and 
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parasol ganglion cells (Dacey et al. 2005; For a review see Feigl & Zele 2014). The 
highest ipRGC density in the human retina is found at the macula (20-25 cells.mm
-2
), 
except at the foveola where they are absent, with density decreasing gradually to the 
periphery (3-5 cells.mm
-2
). Their large dendritic trees spiral around the foveal pit to 
form an extensive plexus and the dendrites stratify within either the inner or outer 
borders of the inner plexiform layer (IPL) (Dacey et al. 2005).  
 
At least five ipRGC subtypes (M1-M5) have been identified in animal models and 
defined based on their morphology and dendritic stratification within the IPL 
(Schmidt et al. 2011b) (Figure 2.3). Most M1 cell bodies (95%) are located in the 
ganglion cell layer (GCL) of retina, with the remaining cell bodies located in the 
inner nuclear layer (INL). M1 dendrites stratify in the outer plexus of the IPL (Dacey 
et al. 2005). The M2, M4 and M5 dendrites stratify in the inner plexus while M3 cells 
are bistratified and their dendrites stratify in both outer and inner margins of the IPL 
(Dacey et al. 2005; Ecker et al. 2010). At present, only M1 and M2 subtypes have 
been identified in humans and primates (Jusuf et al. 2007; Liao et al. 2016).  
 
IpRGCs express the photopigment melanopsin (opn4) which has a peak spectral 
sensitivity around 482 nm, making it maximally sensitive to high irradiance, short-
wavelength (blue) light (Berson 2007; Dacey et al. 2005). M1 cells have the highest 
expression of melanopsin photopigment in mammals, exhibiting a larger intrinsic 
light response than the other subtypes (Ecker et al. 2010) and provide a primary 
afferent signal for most non-image forming functions. IpRGCs also receive extrinsic 
inputs from rods and cones via bipolar and amacrine cells and have a role in image-
forming vision (Dacey et al. 2005; Schmidt, Chen & Hattar 2011a) (Figure 2.3). 
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IpRGCs have demonstrated enhanced survival after optic nerve injury and 
transection in rats (Li et al. 2008; Perez de Sevilla Muller, Sargoy, Rodriguez & 
Brecha 2014) suggesting high injury resistance (Cui, Ren, Sollars, Pickard & So 
2015), although studies in humans show ipRGC dysfunction in patients with 
glaucoma (Feigl, Mattes, Thomas & Zele 2011b; Gracitelli et al. 2014; Kankipati, 
Girkin & Gamlin 2011) and more recently in glaucoma suspects (Adhikari et al. 
2016b). The initial evidence of altered ipRGC function in AMD is shown in a pilot 
study by Feigl and Zele (2014), although little is known about the effect of AMD on 
ipRGC function in various stages of the disease. 
 
Figure 2.3: IpRGC projections within the retinal layers 
The five subtypes of ipRGC cell bodies in the mouse retina lie within the ganglion cell layer 
(GCL) and their dendrites stratify in the outer (M1, M3) and inner (M2-5) margins of the inner 
plexiform layer (IPL). They receive extrinsic inputs from rod and cone photoreceptors via 
amacrine (not shown) and bipolar cells. The RPE interacts with photoreceptors for visual 
function and is separated from the choroid by Bruch’s membrane. 
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Current measures of all three; ipRGCs, rod and cone photoreceptors will be 
discussed in the following.  
 
 MEASURES OF RETINAL FUNCTION 2.3
2.3.1 Photopic and scotopic tests 
Psychophysical measures such as contrast sensitivity (Abadi & Pantazidou 1996; 
Cheng & Vingrys 1993; Kleiner, Enger, Alexander & Fine 1988), glare recovery 
(Bartlett, Davies & Eperjesi 2004; Collins & Brown 1989; Sandberg & Gaudio 
1995), dark adaptation (Brown, Adams, Coletta & Haegerstrom-Portnoy 1986; 
Brown & Kitchin 1983; Dimitrov et al. 2011; Neelam, Nolan, Chakravarthy & 
Beatty 2009; Owsley, Jackson, White, Feist & Edwards 2001; Steinmetz, Haimovici, 
Jubb, Fitzke & Bird 1993) and flicker sensitivity (Dimitrov et al. 2011; Falsini et al. 
2000; Mayer et al. 1992; Phipps, Dang, Vingrys & Guymer 2004; Zele, Cao & 
Pokorny 2008) show impaired retinal function in early stages of the disease. 
Decreased efficiency of the lateral inhibitory mechanisms, mediated by the amacrine 
and horizontal cells, causes only lower contrast spatial frequencies to be seen in 
persons with AMD (Brown & Garner 1983), while increased glare recovery time is 
attributed to reduced metabolic activity in the RPE which is responsible for 
regeneration of the cone photopigment (Glaser, Savino, Sumers, McDonald & 
Knighton 1977; Wu, Weiter, Santos, Ginsburg & Villalobos 1990). Impaired dark 
adaptation is due to the deposition of abnormal material (drusen) in the parafoveal 
region which reduces metabolic supply to the outer retina and subsequently slows 
dark adaptation of rods and cones (Curcio et al. 2000; Feigl 2007; Guymer et al. 
1999; Jackson, Owsley & McGwin 1999; Lamb & Pugh 2004; Steinmetz et al. 
1993). Most of these tests differentiate between cones and rods under photopic 
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(cones only) or scotopic (rods only) illumination hence measure retinal function 
under different adaptation levels and different retinal locations. This is not a true 
representation of visual function in conditions where both rods and cones are active 
under mesopic illumination (Zele, Maynard & Feigl 2013).  
 
Multifocal electroretinography (mfERG) is a promising technique in early detection 
of AMD (Feigl, Brown, Lovie-Kitchin & Swann 2005a; Feigl et al. 2005b, 2006; 
Feigl, Lovie-Kitchin & Brown 2005c; Gerth 2009) using flicker stimulation to elicit 
local retinal responses (Sutter & Tran 1992). MfERG studies by Feigl et al (2007b; 
2008) suggest hypoxia to affect the retinal bipolar cell function in healthy individuals 
due to their location in a watershed zone between retinal and choroidal blood supply, 
thus being deprived of oxygen first. In an attempt to mimic hypoxic conditions as 
experienced in AMD, Feigl et al (2007) demonstrated impaired neuroretinal function 
in response to mild experimental hypoxia that was more pronounced in healthy 
individuals with increasing age (Feigl et al. 2008). MfERG studies show impairment 
of both cone-mediated and rod-mediated mfERG in early and late stages of AMD 
(Feigl et al. 2004, 2005b) with rod-mediated neuroretinal function being impaired 
before cone-mediated function (Feigl et al. 2005b). Although promising for early 
detection of AMD, this is a specialised technique not readily available in clinical 
practice and can be a time consuming procedure (Feigl et al. 2005b; Lovie-Kitchin & 
Feigl 2005).  
 
Due to the paracrine relationship between rods and cones (Mohand-Said et al. 2001), 
the initial loss of rods in AMD may affect cone function, hence the study of mesopic 
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vision provides new opportunities to study retinal function in AMD (Feigl et al. 
2011a). 
 
2.3.2 Mesopic tests 
Clinical tests administered under mesopic (rod and cone active) illumination are 
more sensitive at detecting retinal deficits in advanced AMD when compared to 
photopic or scotopic results (Brown & Garner 1983; Sunness et al. 1997). Under 
physiological conditions, the dark-adapted retina is hypoxic due to increased oxygen 
demand of the rods (Arden, Sidman, Arap & Schlingemann 2005), therefore 
increased metabolic demand of the retina under mesopic conditions amplifies rod-
driven retinal hypoxia. While this oxygen deprivation is tolerated in healthy eyes and 
does not impose major functional deficits, persons genetically at risk for AMD 
and/or with an underlying ischemic condition such as AMD, may present with a 
functional deficit that cannot be compensated for under this additional hypoxia 
condition. This is supported in a recent study by our group (Feigl et al. 2011a), using 
a custom-built four-primary photostimulator (Pokorny, Smithson & Quinlan 2004), 
who demonstrated that mesopic vision testing detects vision loss in healthy 
participants with no clinical signs of AMD but with high risk genotypes for AMD 
(CFH, C allele and ARMS2, T allele) compared to participants with a low genetic 
risk for AMD (CFH, T allele and ARMS2, G allele). This reveals cone pathway 
defects not evident under photopic conditions (Arden et al. 2005; Connolly, Barbur, 
Hosking & Moorhead 2008).  
 
Despite mesopic testing showing higher sensitivity to vision loss than photopic 
testing, high contrast visual acuity (VA) and contrast sensitivity (CS) tests measured 
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under photopic illumination are still the most common measures of macular function 
in a clinical practice. While AMD patients have reduced mesopic VA at both high 
and low contrast (Puell et al. 2012), contrast sensitivity provides a more sensitive 
measure of central visual function than VA as it measures a progressive change in 
luminance differences between test letter and surround rather than under constant 
contrast conditions (Owsley 2003; Pelli, Robson & Wilkins 1988). Therefore, 
mesopic CS may be more sensitive to changes in AMD than mesopic VA which will 
be investigated in this thesis.  
 
In conventional full field perimetry under adaptation levels ranging from 3.18 cd/m
2
 
to 0.00032 cd/m
2
, detection sensitivity increases parafoveally under mesopic 
illumination (Johnson, Keltner & Balestrery 1981), indicating that the increased 
sensitivity of the rods in the parafovea may facilitate stimulus detection through rod-
cone interactions. While microperimetry, a fundus perimetry test that tracks fixation 
and allows for accurate macular sensitivity assessment (Rohrschneider, Bültmann & 
Springer 2008), is traditionally administered under high mesopic conditions, further 
research is needed to determine how microperimetry can be optimised for use under 
low mesopic illumination, thereby establishing a clinically feasible method to detect 
early visual function loss before AMD is manifest, as well as evaluate visual function 
deficits in AMD progression.  
 
2.3.3 Pupillometry 
IpRGCs, rods and cones can be readily and simultaneously measured via the pupil 
light reflex (PLR), an objective measure of visual and pupillary pathways, linking 
retinal, midbrain and autonomic function (Feigl & Zele 2014). Using stimuli of short 
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wavelength near the peak sensitivity of melanopsin that bias activation towards the 
inner retina (ipRGCs) and long wavelength control light to which melanopsin has 
low sensitivity, we can take advantage of the PLR (Figure 2.4) and obtain direct 
measurement of ipRGC function in humans (Markwell et al. 2010; McDougal & 
Gamlin 2010). At stimulus onset, the initial pupil response is driven by rods and 
cones (McDougal & Gamlin 2010), although studies have shown ipRGC contribution 
is necessary for full pupil constriction under high irradiances (Lucas et al. 2003; 
McDougal & Gamlin 2010). During light presentation, the constricted pupil diameter 
is maintained by the outer retina, with increasing inner retina contribution as stimulus 
duration increases (McDougal & Gamlin 2010).  
 
Figure 2.4: Pupil light reflex  
Mean data (n = 20 healthy participants) for a 35° diameter, ten second blue (464 nm) and a 
ten second red (638 nm) 0.5 Hz sinusoid light stimulus. Prior to light onset, baseline pupil 
diameter is recorded. At onset of the light stimulus, pupil constriction occurs and is 
maintained during light presentation. At stimulus offset, the post-illumination pupil response 
(PIPR) for the red light rapidly returns to baseline whereas the PIPR for the blue light is 
sustained. This is the signature response of ipRGCs. 
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The most prominent inner retinal (ipRGC) contribution is the post-illumination pupil 
response (PIPR), the sustained pupil constriction after offset of short-wavelength 
light (Gamlin et al. 2007; Markwell et al. 2010). Adhikari et al (2015b) fitted a 
vitamin A1 nomogram, that matches melanopsin photopigment sensitivity (λmax = 482 
nm), to the measured spectral sensitivities of four PIPR metrics (plateau, 6 s, area 
under early and area under curve late). In this and a second study, they showed that 
the PIPR is rod and melanopsin driven up to 1.7 s post stimulus offset, after which 
the PIPR is completely described by the melanopsin nomogram, thus providing a 
direct measure of the intrinsic melanopsin response (Adhikari, Feigl & Zele 2016a; 
Adhikari et al. 2015b). This validates pupillometry as a non-invasive measure of 
inner retinal function.  
 
Currently six studies have investigated the PLR in persons with AMD (Brozou et al. 
2009; Feigl & Zele 2014; Rosli, Bedford, James & Maddess 2012; Sabeti, James, 
Essex & Maddess 2013; Sabeti, Maddess, Essex & James 2011), but only our group 
has directly measured ipRGC function (Feigl & Zele 2014). Although a visual 
function deficit in AMD participants was found using the PLR, Brozou et al (2009) 
focused on the pupil constriction amplitude and velocity, thus only considering the 
outer (rod and cone) retina driven pupil response. In two separate studies, Sabeti et al 
(2013; 2011) use multifocal pupillography (mfPOP) to assess local retinal function in 
persons with early AMD (Sabeti et al. 2013) and exudative AMD (Sabeti et al. 2011) 
compared to age-matched controls. Mean constriction amplitudes and time to peak 
delays in AMD participants were decreased; however, mfPOP only assesses the outer 
retina. Rosli et al (2012) followed a similar protocol with the mfPOP, but evaluated 
outer retina driven pupil responses in patients ranging from early to late AMD under 
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scotopic and photopic conditions and found that mfPOP testing under photopic 
conditions provides better diagnostic results for detecting photoreceptor deficits. 
Pilot data from our laboratory that measured the ipRGC response to long and short 
wavelength light show that persons with early and late signs of AMD have a reduced 
sustained post-illumination pupil response to short-wavelength light compared to 
healthy age-matched controls providing preliminary evidence of ipRGC dysfunction 
in AMD (Feigl & Zele 2014). It is still not known whether ipRGC dysfunction has 
further reaching non-visual effects in AMD due to their projections to multiple brain 
areas.   
 
 IPRGC FUNCTION AND SLEEP IN ADVANCED AMD 2.4
One of the key functions of ipRGCs is the intrinsic signalling of photic input to 
the suprachiasmatic nucleus (SCN) for the entrainment of the circadian rhythm 
(Berson et al. 2002). Normal photoentrainment occurs in the absence of rod and cone 
photoreceptors in mice (Ebihara & Tsuji 1980; Foster et al. 1991; Freedman et al. 
1999; Lucas et al. 2001b) which is also seen in certain blind humans (Klerman et al. 
2002). Interestingly, melanopsin knockout mice retain the ability to entrain light and 
dark cycles, albeit to a lesser degree (Panda et al. 2002; Ruby et al. 2002), indicating 
that both classic rod and cone photoreceptors and ipRGCs contribute to circadian 
photoentrainment. Ophthalmic diseases may reduce photic input to the SCN, thereby 
affecting the circadian rhythm and causing sleep disturbances. There is a high 
frequency of sleep disturbances in people with vision loss who retain light 
perception, becoming more severe and more common in people with total vision loss 
and no light perception (Tabandeh et al. 1998). Sleep disorders have been linked to 
glaucoma (Agorastos et al. 2013; Ayaki, Shiba, Negishi & Tsubota 2016; Jean-Louis, 
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Zizi, Lazzaro & Wolintz 2008; Wang, Zhang, Ding & Wang 2013) which has further 
been associated with ipRGC dysfunction (Gracitelli et al. 2016; Gracitelli et al. 2014; 
Gracitelli et al. 2015). Altered sleep duration has been demonstrated in AMD 
patients (Khurana et al. 2016; Pérez-Canales et al. 2016) although no link has been 
established with ipRGC function. The association between sleep and ipRGC function 
in AMD may provide further insight into the ipRGC projections to the SCN and the 
effect of AMD on these projections.     
 
 IPRGC FUNCTION AND DEPRESSION IN ADVANCED AMD 2.5
There is a high risk of depression in patients with low vision (Evans, Fletcher & 
Wormald 2007; Nollett et al. 2016; van der Aa, Comijs, Penninx, van Rens & van 
Nispen 2015) and with AMD (Augustin et al. 2007; Cimarolli et al. 2016; Jivraj, 
Jivraj, Tennant & Rudnisky 2013; Mathew et al. 2011), with up to 33% of persons 
with AMD meeting criteria for major depression (Brody et al. 2001; Rovner & 
Casten 2002) compared to the rate of depression among non-institutionalized older 
people that ranges between 8 and 16% (Blazer 2003). This has been attributed to 
functional disabilities and loss of independence associated with reduced vision in one 
or both eyes (Brody et al. 2001; Casten & Rovner 2013; Jivraj et al. 2013; Popescu et 
al. 2012; Varano et al. 2016). A role of ipRGCs in regulating mood has been 
identified in rodent models by LeGates et al (2012) who showed that aberrant light 
cycles in wild type mice caused increased depression-like behaviours. However, in 
mice that lack ipRGCs, the aberrant light cycle did not impair mood and learning, 
demonstrating the ability of light to influence cognitive and mood functions directly 
through ipRGCs (LeGates et al. 2012). In a human study, the PIPR to blue light 
stimuli in persons with seasonal affective disorder (SAD) was significantly reduced 
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compared to a control group, indicating reduced ipRGC sensitivity (Roecklein et al. 
2013). Further, persons with gene variants (rs2675703, P10L, TT allele) in the 
melanopsin (opn4) photopigment had a 5.6 times higher risk of developing SAD 
(Roecklein et al. 2009). This suggests an association between ipRGC dysfunction 
and the increased prevalence of depression; however, the link between depression 
and ipRGC dysfunction in AMD is still to be determined. 
 
 SUMMARY  2.6
In conclusion, AMD is one of the most prevalent causes of central vision loss and 
yet its pathomechanisms are still unclear. The loss of vision has far-reaching effects, 
impacting quality of life and costing millions in health care. Whilst there is still no 
cure for AMD, it is possible to slow its progression with supplements and lifestyle 
changes if detected early. Also, the prognosis for CNV patients undergoing anti-
VEGF treatments is better, with retention and in some cases even improvement in 
visual acuity after injections, provided the disease is detected early and photoreceptor 
damage and death is minimised. 
  
This thesis focuses on understanding the effect of AMD on retinal function with the 
aim to advance clinically available visual testing procedures to identify early retinal 
dysfunction before funduscopic changes are visible. By determining the link between 
retinal function and the presence of sleep and depression in AMD, further insight 
into its non-visual effects may be acquired.   
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 AIMS AND HYPOTHESES 2.7
2.7.1 Experiment 1 (Chapter 4) 
Current clinical tests of outer retinal function are typically administered under 
either photopic illumination (cone photoreceptor mediated visual function only) or 
scotopic illumination (rod photoreceptor mediated visual function only) although 
mesopic tests, mediated by both rods and cones, have higher sensitivity to vision loss 
(Brown & Garner 1983; Feigl et al. 2011a; Sunness et al. 1997). By developing new 
paradigms to measure outer retinal function under mesopic illumination, clinically 
established instruments (Pelli-Robson contrast sensitivity and MP-1 microperimeter) 
can be modified to provide a more sensitive means to detect early changes in AMD 
and potentially detect early retinal function deficits in persons genetically at risk for 
AMD. These new developments will allow for early dietary and lifestyle intervention 
that may delay onset or progression of AMD. 
 
Aim 
To determine whether low mesopic contrast sensitivity and microperimetry are more 
sensitive to vision changes occurring with healthy ageing and in early and 
intermediate age-related macular degeneration (AMD) and whether these mesopic 
tests can differentiate visual function between healthy older participants with and 
without AMD risk genotypes.  
 
Hypothesis 
o Mesopic contrast sensitivity and microperimetry tests can detect functional 
deficits before photopic tests in early and intermediate AMD that can be 
differentiated from normal ageing.  
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o Healthy, high risk genotypes show greater reduction in retinal function under 
mesopic illumination compared to healthy, low risk genotypes.  
 
2.7.2 Experiment 2 (Chapter 5) 
As AMD affects both outer and inner retinal function, analysis of the pupillary 
light reflex could provide a new diagnostic tool for obtaining information on rod and 
cone photoreceptor function and ipRGC function in early stages of AMD, as well as 
provide a useful technique in documenting the progression of AMD. Understanding 
how ipRGCs are affected may add to our knowledge of the pathomechanisms and 
progression of AMD.  
Aim 
To determine inner retinal inputs to the pupil control pathway in persons with early 
or intermediate AMD using customized pupillometry protocols. 
 
Hypothesis 
o Persons with early stages of AMD will show reduction of inner (ipRGC) retinal 
function compared to healthy age-matched controls, with function reducing 
progressively with advancing disease. 
 
2.7.3 Experiment 3 (Chapter 6) 
Poor sleep quality and a high risk of depression is associated with AMD and 
emerging evidence has identified a role of the intrinsically photosensitive retinal 
ganglion cells (ipRGCs) in regulating circadian rhythm and mood. Measurement of 
the pupil light reflex in conjunction with a patient sleep and depression questionnaire 
will provide the initial determination whether ipRGC dysfunction is linked to sleep 
disturbances and depression in persons with AMD. 
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Aim 
To determine whether an ipRGC functional deficit is associated with depression and 
sleep disorders in persons with advanced AMD. 
 
Hypothesis 
o We hypothesize that persons with reduced ipRGC function will have poorer 
sleep and increased depression scores compared to persons with normal ipRGC 
function. 
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 Research Design Chapter 3:
This chapter describes the experimental design, participant characteristics and 
methodology used in each experiment. These include determination of mesopic light 
levels in pilot trials and participant genotyping in experiment 1 (Chapter 4), 
development of the custom-built and commercial pupillometer paradigms used in 
experiments 2 (Chapter 5) and 3 (Chapter 6), methods of sleep and depression 
assessment (Chapter 6), as well as the description of data analysis and statistical 
modelling for each experiment. 
 
 EXPERIMENT 1 3.1
3.1.1 Participants 
A total of 119 participants (age range 19 – 85 years) were recruited from 
volunteers at Queensland University of Technology (QUT) and the QUT Eye clinic. 
Ninety-eight participants (47 M and 51F) had no ocular disease and served as the 
healthy ageing group. Twenty-one participants (11M and 10F; age 73.9 ± 6.5 years) 
had early or intermediate AMD in both eyes (AREDS grade 2 or 3) based on the 
results of two independent gradings of the fundus photographs (Age-Related Eye 
Disease Study Research Group 2001b).  
 
3.1.2 Methodology 
Contrast sensitivity 
Contrast sensitivity was measured using the Pelli-Robson wall chart (Pelli et al. 
1988) under both photopic and mesopic conditions. The test is administered under 
bright ambient (photopic) room illumination in clinical practice. The Pelli-Robson 
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chart provides a quick, reliable and repeatable method for measuring contrast 
sensitivity (Elliott, Sanderson & Conkey 1990; Reeves, Wood & Hill 1993) with 
participants required to read the lowest contrast letter they can see. A thorough 
description of the chart and testing procedures is given in Chapter 4 (Section 4.4.2). 
In brief, the wall mounted chart comprises letters arranged in 8 lines with two triplets 
per line. Contrast levels within each triplet are the same and contrast decreases by a 
factor of 0.15 log units in each successive triplet, reading from left to right and down 
the chart (Figure 3.1).  
 
  
Figure 3.1: Pelli-Robson contrast sensitivity chart and score card 
The left panel is an example of the Pelli-Robson contrast sensitivity chart. Each letter triplet 
decreases in contrast by 0.15 log units. The right panel is a key to the Pelli-Robson chart 
with the marginal numbers giving the log contrast sensitivity corresponding to the 
neighbouring letter triplet. 
 
 
0.00 V R S K D R 0.15 
0.30 N H C S O K 0.45 
0.60 S C N O Z V 0.75 
0.90 C N H Z O K 1.05 
1.20 N O D V H R 1.35 
1.50 C D N Z S V 1.65 
1.80 K C H O D K 1.95 
2.10 R S V H V R 2.25 
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Room illumination was measured using a calibrated ILT1700 Research Radiometer 
(International light Technologies, Inc., Peabody, USA) at several locations around 
the vision testing room, at a height consistent with eye level of a seated patient. The 
light sensor was positioned both vertically, facing the ceiling, and horizontally, 
facing the centre of the room. Three repeated measures for each position and location 
were taken and the mean room illumination was calculated. A final measurement 
taken at the position of a seated patient, facing the Pelli-Robson wall chart, 
confirmed the room illumination under testing conditions. Participants were seated 
1m from the chart and the photopic condition was completed first under a mean room 
illumination of 85 lux. A dimmer switch was used to reduce the room illumination to 
a mean level of 1.04 lux for the mesopic test conditions and participants dark adapted 
for 5 minutes prior to reading the chart under mesopic illumination.  
 
Microperimetry 
Mean macular sensitivity was measured using the MP-1 microperimeter (Nidek 
Technologies, Japan), a commercially available automatic fundus perimeter that 
allows for precise assessment of macular sensitivity under real-time conditions 
(Rohrschneider et al. 2008). The retina is observed using an infrared camera and 
automatic eye tracking accounts for eye movement, ensuring exact retinal location 
assessment. The software provides a number of standard testing conditions such as 
static threshold or kinetic fundus perimetry, as well as allowing for customisation of 
these programs. In this study, threshold macular sensitivity (dB) was measured under 
standard mesopic and reduced mesopic illumination using a 4-2 staircase strategy 
with a 200 ms white stimulus presented to 40 retinal points (Figure 3.2). This 
protocol ensured measurement of the entire parafoveal region whilst minimising 
testing time and thereby reducing the effect of fatigue (Convento & Barbaro 2007). 
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Pupils were dilated to control retinal illumination. Test durations for both standard 
and reduced mesopic conditions were approximately 10 minutes after a practise test 
was completed to avoid the influence of a learning effect (Wu, Ayton, Guymer & 
Luu 2013). 
For standard conditions, stimuli were presented on a background luminance of 1.27 
cd.m
-2
, as provided by the manufacturer. For determination of the lower mesopic 
conditions for the microperimeter, a pilot study was conducted with 5 participants 
using a selection of neutral density filters (including 0.1, 0.2, 0.3, 0.5 and 1 ND’s) 
positioned in front of the ocular tube. The internal camera was unable to maintain 
fundus tracking with the 0.3, 0.5 and 1 ND filters, therefore the maximum 
attenuation achieved without affecting the camera tracking ability was with a 0.2 
neutral density (ND) filter which reduced the background to a lower mesopic 
luminance of 0.801 cd.m
-2
. Attachment of the ND filter to the front of the 
microperimeter ocular tube produced a reflection which affected the patient’s ability 
to see the fixation cross and test stimuli. Interference filters of various wavelengths 
were used to test the possibility that the MP-1 light was narrowband and would 
eliminate the reflection; however the reflection increased and in some cases produced 
a band reflection across the fundus picture. The reflection was finally overcome by 
rotating the ND filter by 35° around the vertical axis until it was in the patient’s far 
peripheral temporal field (Figure 3.2B). A BM7 luminance colorimeter (Topcon, 
Tokyo, Japan) measured the change in ND attenuation at 0° and at 35° rotation for 
the 0.2 ND filter and the results are given in table 3.1. The change in luminance 
caused by rotating the ND filter was negligible and pilot testing on 3 healthy 
participants showed no effect of the reflection in the far peripheral visual field 
compared to normal results. 
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Table 3.1: Change in luminance (cd/m2) with the neutral density (ND) filter rotated 
around the vertical axis 
 
No ND 0.2 ND 
0° rotation 8.69 x 10
2 
5.66 x 10
2
 
 8.71 x 10
2
 5.67 x 10
2
 
 8.71 x 10
2
 5.66 x 10
2
 
35° rotation  5.57 x 10
2
 
  5.63 x 10
2
 
  5.59 x 10
2
 
 
 
Figure 3.2: Microperimeter pilot data with and without neutral density (ND) filter  
Retinal photographs of the right eye of a test participant under standard conditions (panel A) 
and low mesopic conditions with ND (panel B) are shown. Macular sensitivity (dB) is 
measured at 40 retinal points. The concentric rings (insert) are used to compare sensitivity in 
retinal areas at 2° (600 μm), 6° (1800 μm) and 10° (3000 μm) from the macular centre. The 
red cross in the centre of the insert shows the fixation point and the collection of blue points 
show the participant’s fixation throughout the test. The optic nerve head (ONH) (blind spot) 
is used for reliability measures of the participant’s fixation. The reflection from the ND filter 
is seen in panel B in the temporal retina.  
ONH 
2° 
6° 
10° 
A B 
Insert 
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Genotyping  
Saliva samples were collected from participants using self-collection kits 
(Oragene DNA self-collection kit, DNA Genotek Inc, Ottawa, Ontario, Canada) 
according to established procedures (Feigl et al. 2011a; Feigl et al. 2012a; Feigl, 
Morris, Voisey, Kwan & Zele 2014) and DNA genotyping was performed to screen 
for genetic variants most commonly associated with AMD (Ross, Verma, Rosenberg, 
Chan & Tuo 2007). These include the SNPs in the Complement Factor H gene (CFH 
Y402H; rs1061170), as well as Age-Related Maculopathy Susceptibility 2 (ARMS2; 
rs10490924), which identify individuals at high, medium and low risk of developing 
AMD (Table 3.2). DNA extraction and genotyping was performed commercially at 
the Genomics Research centre, Queensland University of Technology, Australia 
using a restriction fragment length polymorphism (RFLP) technique. 
 
Table 3.2: Risk alleles for SNPs in the CFH and ARMS2 genes 
 
CFH Y402H 
(rs1061170) 
ARMS2    
(rs10490924) 
Homozygous high risk allele CC TT 
Homozygous low risk allele TT GG 
Heterozygous risk allele CT GT 
 
 
 
3.1.3 Data Analysis 
Contrast sensitivity was scored under photopic and mesopic illumination as the 
lowest contrast level at which at least two of the three letters in a triplet was 
identified correctly (Pelli et al. 1988) (Figure 3.1). Linear regression analysis 
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determined the effect of healthy ageing and onset of AMD on contrast sensitivity as 
measured under different illumination levels.  
Microperimetry data were assessed in three concentric annuli; eight retinal points at 
2° eccentricity and 16 retinal points at both 6° and 10° eccentricities were assessed 
(Figure 3.2). Mean sensitivity was calculated over the 40 retinal points and also 
compared within and between the concentric rings to evaluate the effect of 
eccentricity on retinal function. Threshold sensitivity was given in decibels (dB), 
increasing from 0 dB (maximum contrast required to see stimulus), in 2 dB 
increments, to 20 dB (minimum contrast required to see stimulus). To allow direct 
comparison of the standard microperimetry and low mesopic microperimetry data, 
the decibel values were converted to macular sensitivity (%). The decibel 
conversions are given in Table 3.3. Differential luminance is provided in the MP-1 
manual for each decibel value and the background luminance is given as 1.27 cd.m
-2
. 
Maximum luminance is the sum of the differential and background luminance. Under 
control conditions, this was equal to 128.7 cd.m
-2
 while under low mesopic 
conditions, maximum luminance was equal to 80.93 cd.m
-2. Change in luminance 
(ΔL) is equal to the difference between maximum luminance and background 
luminance (L). The low mesopic differential luminance was calculated by raising the 
provided differential luminance to the power of the ND filter (0.2 ND) and the low 
mesopic background luminance was calculated as 0.801 cd.m
-2
. Weber contrast 
threshold (%) was calculated (ΔL/L) and the inverse taken as macular sensitivity. 
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Table 3.3: MP-1 decibel to contrast sensitivity conversion 
Stimulus 
Attenuation 
(dB) 
Standard 
Differential 
Luminance 
Mesopic  
Differential 
Luminance 
Threshold 
(%) 
Sensitivity 
(%) 
0 127 80.1 100.0          1.0 
1 101 63.7 79.5 1.3 
2 80.3 50.7 63.2 1.6 
3 63.8 40.3 50.2 2.0 
4 50.6 31.9 39.8 2.5 
5 40.2 25.4 31.7 3.2 
6 31.9 20.1 25.1 4.0 
7 25.4 16.0 20.0 5.0 
8 20.1 12.7 15.8 6.3 
9 16 10.1 12.6 7.9 
10 12.7 8.0 10.0 10.0 
11 10.1 6.4 8.0 12.6 
12 8.03 5.1 6.3 15.8 
13 6.38 4.0 5.0 19.9 
14 5.07 3.2 4.0 25.0 
15 4.03 2.5 3.2 31.5 
16 3.2 2.0 2.5 39.7 
17 2.54 1.6 2.0 50.0 
18 2.02 1.3 1.6 62.9 
19 1.6 1.0 1.3 79.4 
20 1.27 0.8 1.0 100.0 
 
Linear regression analysis was performed to determine the effect of ageing and onset 
of AMD on macular sensitivity under standard and low mesopic illumination for 
control participants and AMD patients. Descriptive statistics were used to report the 
effect of AMD risk genotypes on macular sensitivity (CS and MP-1) in the healthy 
older participants.     
 
 EXPERIMENT 2 3.2
3.2.1 Participants 
Forty participants (20 M, 20 F) were recruited from the Queensland University of 
Technology (QUT) eye clinic. Twenty participants (10F and 10M; age 69.3 ± 5.5 
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years) with no ocular disease served as healthy controls and 20 participants had early 
or intermediate AMD (10F and 10M; age 72.9 ± 6.3 years) with either AREDS grade 
2 or grade 3 AMD based on the results of two independent gradings of the fundus 
photographs (Age-Related Eye Disease Study Research Group 2001b). The same 
AMD patients from experiment 1 participated in experiment 2, however, a different 
cohort of healthy control participants were recruited. 
 
3.2.2 Methodology 
Maxwellian view pupillometer 
A custom-built pupillometer in our laboratory (Adhikari et al. 2015b; Feigl & 
Zele 2014; Joyce, Feigl, Cao & Zele 2015; Kankipati, Girkin & Gamlin 2010) was 
used to measure the PLR in AMD and healthy participants using 10 s sinusoidal 
stimuli. The optical system (Figure 3.3) was arranged in an extended Maxwellian 
view (Westheimer 1966) consisting of LED light sources imaged in the pupil plane 
of the eye via two Fresnel lenses (100 mm diameter, 127 mm  and 70 mm focal 
lengths; Edmund Optics, Singapore) and a 5º light shaping diffuser (Physical Optics 
Corp., California USA). These, along with an aperture and filter holder, were placed 
on a same line within an enclosure. The two interchangeable LEDs (464 and 638 nm) 
were placed at one end of the enclosure and the participant’s right eye was aligned at 
the other end. The left eye was illuminated with an 851 nm infrared LED and aligned 
with a Pixel link infrared (IR) camera (PL-B741 FireWire, 640 x 480 pixels) attached 
to the computer. Thirty five degree diameter, 15.1 log photons.cm
-2
.s
-1
, 0.5 Hz 
sinusoidal light stimulus was presented to the right eye and the consensual pupillary 
response was measured in the left eye. The baseline pupil diameter was measured 
after 13 s of fixation before the onset of the light stimulus and the post-stimulus 
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response was recorded for 40 s. Stimulus presentation, pupil recording and pupil 
analysis were controlled by custom Matlab software (version 7.12.0, Mathworks, 
MA, USA).  
 
Figure 3.3: Custom-built Maxwellian view pupillometer photograph and schematic  
A long (638 nm) or short (464 nm) wavelength LED is rotated into position at the focal plane 
(f1) of a Fresnel lens (F1) which collimates divergent light from the LED. The light rays are 
homogenised by a diffuser (D), pass through an aperture (A) which controls the stimulus 
diameter and are converged by a second Fresnel lens (F2) positioned at the focal length of the 
pupil plane (f2) of the participant’s dilated right eye (RE). The undilated left eye (LE) is 
illuminated by an infrared LED (IR) and aligned using mirrors (M) with an infrared camera 
that records the consensual pupil response. Schematic is not drawn to scale.  
(Photograph source: Zele AJ) 
 
 
 
3.2.3 Data Analysis 
Custom offline analysis performed in Matlab fitted two ellipses to the pupil and 
the average diameter was obtained. The data were fitted with linear and exponential 
models (Feigl & Zele 2014; Zele, Feigl, Smith & Markwell 2011) and the pupil light 
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reflex (PLR) defined in terms of baseline pupil diameter (average pupil diameter 
before light stimulus onset), constriction amplitude (minimum pupil diameter during 
onset of light stimulus) and post-illumination pupil response (PIPR) (sustained pupil 
constriction after light stimulus offset). The newly defined PAP (phase amplitude 
percentage) metric (Feigl & Zele 2014), calculated as (
638𝑛𝑚−464𝑛𝑚
638𝑛𝑚
) 𝑥 100, used 
the phasic response during light stimulation to measure inner and outer retinal 
interactions. As ipRGCs contribute to maintaining pupil constriction during stimulus 
presentation, the peak-to-trough amplitude for the short wavelength sinusoid 
stimulus is lower than that of the long wavelength stimulus under normal conditions 
(Feigl & Zele 2014; Güler et al. 2008; McDougal & Gamlin 2010). In retinal disease 
conditions, ipRGC loss or dysfunction would reduce pupil constriction during light 
stimulation, resulting in a similar peak-to-trough amplitude for both high and low 
melanopsin excitation stimuli (i.e. a lower PAP). Therefore, the phase amplitude 
percentage (PAP) was calculated as the difference in peak-to-trough amplitude 
between the long and short wavelength PLR during sinusoidal stimulus presentation. 
Figure 3.4 shows the pupil light reflex for one participant in response to 10 s short 
wavelength (464 nm) and 10 s long wavelength (638 nm) sinusoidal light stimuli 
with the best fit models to the data.  
 
Statistical analysis of the long and short wavelength stimulus responses was 
performed using repeated measures ANOVA and appropriate post-hoc analysis, 
within and between groups. Independent samples Mann-Whitney U test was used 
where data were not normally distributed. The PAP was evaluated using independent 
samples t-tests. The diagnostic accuracy of the PIPR metrics in determining early 
 Research Design 
AMD was evaluated using receiver operator characteristic (ROC) analysis by 
quantifying the difference between the AMD patients and control participants. 
 
Figure 3.4: Pupil light reflex 
The figure shows data for a ten second blue (464 nm) and a ten second red (638 nm) 0.5 Hz 
sinusoidal light stimulus and best fit linear and exponential models. Prior to light onset, 
baseline pupil diameter is recorded. At onset of the light stimulus, pupil constriction occurs, 
maintained during light presentation. At stimulus offset, the post-illumination pupil response 
(PIPR) for the red light rapidly returns to baseline whereas the PIPR for the blue light is 
sustained. The PIPR is measured at 6 s post-stimulus offset. 
 
 
 EXPERIMENT 3 3.3
3.3.1 Participants 
Seventy-three participants (41 F and 32 M) were recruited from the Queensland 
Eye Institute (QEI), Queensland University of Technology (QUT) eye clinic and two 
local optometry practices. Forty six of these participants (30F and 16M; age 78.4 ± 
8.7 years) had advanced neovascular AMD (CNV) (AREDS grade 4) (Age-Related 
Eye Disease Study Research Group 2001b) and were under treatment with anti-
vascular endothelial growth factor (Lucentis
®
 or Eylea
®
). Seven participants (3F and 
4M; age 80.7 ± 9.7 years) had advanced geographic atrophy (GA) (AREDS grade 4) 
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and twenty participants (8F and 12 M; age 72.5 ± 3.3 years) served as age-matched 
healthy controls. All participants for experiment 3 were newly recruited.  
 
3.3.2 Methodology 
RAPDx pupillographer 
Testing for this experiment occurred offsite at the Queensland Eye Institute and 
required portability of the pupillometry. A RAPDx pupillographer (Konan Medical, 
USA, Inc., Irvine, CA) (Figure 3.5), a commercially available system, was modified 
for our study protocols. Monocular long and short wavelength stimuli were presented 
in Newtonian view on a liquid crystal display (LCD) with a 40 Hz frame rate while 
recording the binocular pupil responses under infrared conditions. A target (green 
cross) was used for patient fixation and a central physical barrier created two optical 
channels. The screen was viewed at infinity through a pair of 50-mm objective lenses 
for a field of view of approximately 25° in each eye (Konan Medical, USA). To 
measure the PIPR, customised pupil paradigms were developed for use with this 
instrument based on pilot studies conducted by our research group and completed on 
the custom-built Maxwellian view pupillometer (Section 3.2.2).  
 
Monochromatic stimuli included 10 s pulses of blue light (short wavelength, 
λmax = 448 nm, corneal irradiance: 14.5 log quanta.cm
−2
.s
−1
, luminance: 1.3 log 
cd.m
−2) with high melanopsin excitation (609.8 α-opic lux) and red light (long 
wavelength, λmax = 604 nm, corneal irradiance: 14.4 log quanta.cm
−2
.s
−1
, 
luminance: 1.0 log cd.m
−2) with low melanopsin excitation (9.7 α-opic lux). The 
test stimulus was presented to one eye and the PLR of both eyes recorded. The 
baseline pupil diameter was measured during 5 s of fixation before the onset of the 
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10 s light stimulus and the post-stimulus response was recorded for 40 s. The spectral 
outputs of the LED stimuli were measured with a Spectroradiometer (StellarNet, 
Tampa, FL, USA) and irradiance was calibrated with an ILT1700 Research 
Radiometer (International Light Technologies, Peabody, Mass, USA).  
 
Figure 3.5: RAPDx pupillographer 
The participant is positioned with their 
forehead against the rubber faceplate and 
their outer canthus adjacent to the mark 
on the side of the faceplate. The 
moveable touch screen can be positioned 
rear-facing, or to the left or right of the 
machine. The operator aligns the eyes 
with vertical and horizontal alignment 
lines on the screen. There is automatic 
tracking of the pupillary response once 
the test starts. The test can be paused at 
any time. 
(Source: http//konanmedical.com/rapdx) 
 
 
Pittsburgh sleep quality index (PSQI) 
Sleep quality was assessed using the PSQI questionnaire (Buysse, Reynolds, 
Monk, Berman & Kupfer 1989). This is a self-administered questionnaire primarily 
used to measure sleep quality in terms of ‘poor’ or ‘good’ sleepers. The PSQI 
comprises 19 questions grouped into seven sleep quality components (subjective 
sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, sleep 
medication and daytime dysfunction). Each component is scored from 0 to 3 with 3 
representing the negative extreme on the Likert scale, thus a higher score indicates 
poorer sleep quality. The component scores are summed to provide a global score 
and a score of > 5 provides a sensitive and specific measure of poor sleep relative to 
clinical and laboratory measures (Buysse et al. 1989). The PSQI has high test-retest 
reliability (Backhaus, Junghanns, Broocks, Riemann & Hohagen 2002; Buysse et al. 
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1989), as well as a diagnostic sensitivity of 89.6% and specificity of 86.5% (Buysse 
et al. 1989). The PSQI has been used to determine sleep disturbances in glaucoma 
(Ayaki et al. 2016; Wang et al. 2013) and the circadian response of ipRGCs (Zele et 
al. 2011).  
 
Centre for epidemiologic studies depression scale (CES-D) 
 The CES-D questionnaire (Radloff 1977) determined the presence and risk of 
depression in the participants. This questionnaire is a self-report test, simplified from 
previously validated longer questionnaires, designed to measure symptoms 
associated with depression in the general population. The twenty item CES-D 
questionnaire comprises six scales reflecting the major facets of depression: 
depressed mood, feelings of guilt and worthlessness, feelings of helplessness and 
hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance. These 
symptoms have been used in previously validated scales and the CES-D has high 
test-retest reliability and internal consistency (Radloff 1977). Copies of these 
questionnaires can be found in the appendix. 
 
3.3.3 Data Analysis 
The PLR was fitted with linear and exponential models (Feigl & Zele 2014; Zele 
et al. 2011) and analyzed according to our established protocols (Adhikari et al. 
2015b). To control for individual differences in resting pupil diameter, all data are 
reported as a percentage of the resting baseline pupil diameter (average pupil 
diameter during 5 s pre-stimulus period). The PIPR was quantified at six seconds 
after light stimulus offset (Park et al. 2011). The PSQI questionnaire was scored and 
analysed using the global sleep score, sleep quality factor and sleep efficiency factor 
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(Magee, Caputi, Iverson & Huang 2008). Sleep quality included scores from the 
subjective sleep quality, sleep latency and sleep disturbance components, while sleep 
efficiency included scores from sleep duration and calculated sleep efficiency 
components. Sleep factor scores were calculated by multiplying the component score 
by the factor loading given by Magee et al (2008) and summing them. The CES-D 
questionnaire was scored on a Likert scale from 0 to 3 with higher scores indicating 
more symptoms, weighted by frequency of occurrence during the past week (Radloff 
1977). A cut-off score of 16 aids in identifying people at risk for clinical depression. 
Using component scoring criteria as described by Radloff (1977), patients were 
identified as having no clinically significant depression symptoms, sub-threshold 
depression symptoms, possible or probable major depressive symptoms or having 
met major depressive episode criteria. 
 
Independent samples t-tests evaluated each component (PIPR, sleep quality, sleep 
efficiency and level of depression) between the control group and AMD group as 
well compared the difference in mean PIPR, sleep and depression scores between 
CNV and geographic atrophy (GA) patients. Spearman’s correlation coefficient and 
linear regression analysed the relationship between the PIPR and sleep (global score, 
sleep quality and sleep efficiency), as well as between the PIPR and depression 
scores within groups.  
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 Mesopic Pelli-Robson contrast Chapter 4:
sensitivity and MP-1 microperimetry in 
healthy ageing and age-related macular 
degeneration 
 ABSTRACT  4.1
4.1.1 Purpose  
To determine whether decreasing illumination of the Pelli-Robson contrast 
sensitivity (CS) chart and MP-1 microperimeter to low mesopic conditions is more 
sensitive to vision changes occurring with healthy ageing and in early and 
intermediate age-related macular degeneration (AMD) and whether these mesopic 
tests can differentiate visual function between healthy older participants with and 
without AMD risk genotypes. 
4.1.2 Methods  
Retinal sensitivity was measured in 98 healthy participants (19-85 years) and 21 
AMD (AREDS Grade 2/3) patients (73.9±6.5 years) using the Pelli-Robson CS chart 
and MP-1 microperimeter under low mesopic and standard illumination. The effect 
of ageing and AMD on retinal sensitivity was estimated using regression analysis. 
Healthy older participants (>50 years; n=24) were genotyped for AMD risk genes 
CFH and/or ARMS2 and retinal sensitivity was compared between genotypes.  
4.1.3 Results  
With healthy ageing, photopic and mesopic Pelli-Robson CS showed a similar 
decline (-0.004 log CS/year). In AMD, photopic CS showed a similar decline to 
healthy ageing (-0.004 log CS/year) while mesopic CS was significantly reduced (-
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0.007 log CS/year). Both standard and low mesopic microperimetry showed a 
significant decline (-0.51 and -0.73 % contrast/year) with healthy ageing and greater 
decline (-0.73 and -0.99 % contrast/year) with AMD onset. Pelli-Robson CS and 
microperimetry sensitivity did not differ between AMD risk genotypes.  
4.1.4 Conclusions  
Mesopic Pelli-Robson CS detects functional deficits before photopic CS in early 
and intermediate AMD that can be differentiated from normal ageing. This test can 
be easily administered in clinical practice and may provide a means for early 
detection of retinal dysfunction.  
 KEY WORDS  4.2
Mesopic, contrast sensitivity, microperimetry, macular degeneration 
 INTRODUCTION 4.3
Age-related macular degeneration (AMD) is a progressive condition affecting 
central vision and a leading cause of blindness in older adults worldwide (Friedman 
et al. 2004; Klein et al. 1992; Mitchell et al. 1995). Despite intensive research, its 
pathogenesis is still unclear but AMD has been described as a disease exhibiting the 
characteristics of accelerated ageing (Ardeljan & Chan 2013). There is currently no 
cure for AMD and attention has turned towards early detection of macular changes to 
facilitate lifestyle and dietary modifications that may slow or even halt disease 
progression (Mares et al. 2011).  
 
There has been significant focus on understanding cone (photopic) and rod (scotopic) 
mediated visual function with both showing a reduction with age and in early AMD 
(Cheng & Vingrys 1993; Feigl et al. 2004, 2005b; Hogg & Chakravarthy 2006; 
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Lovie-Kitchin & Feigl 2005; Neelam et al. 2009; Swann & Lovie-Kitchin 1991). 
Mesopic vision offers great potential for the development of new tests for the early 
detection of retinal diseases affecting both the rods and cones (for review, Zele & 
Cao 2015). For the early detection of AMD, low luminance/low contrast and 
mesopic vision tests of combined rod and cone function have been recommended 
(Feigl et al. 2011a; Lovie-Kitchin & Feigl 2005). Indeed, mesopic critical fusion 
frequency (CFF) is lower in healthy persons with no retinal disease but who have 
high risk AMD genotypes when compared to healthy persons with low risk 
genotypes (Feigl et al. 2011a). Nevertheless, high contrast visual acuity (VA) and 
contrast sensitivity (CS) tests are still the most common measures of macular 
function in a clinical practice. While mesopic vision testing shows higher sensitivity 
to vision loss than photopic testing, most scotopic and mesopic psychophysical and 
electrophysiological tests have not made their entrance into clinical practice.  
 
In this study we investigated two clinical tests that assess central retinal function; the 
Pelli-Robson contrast sensitivity chart (Pelli et al. 1988) and MP-1 microperimetry, a 
newer technology which shows promise in the localized functional documentation of 
vision in AMD (Dinc, Yenerel, Gorgun & Oncel 2007; Meleth et al. 2011; Midena et 
al. 2007; Parravano et al. 2009; Pilotto et al. 2013; Rohrschneider et al. 2008; Tarita-
Nistor, Gonzalez, Markowitz & Steinbach 2008; Wu, Ayton, Guymer & Luu 2014). 
Our aim was to determine whether modification of these clinical tests to measure 
vision under low mesopic illumination is more sensitive to changes in retinal 
function due to normal ageing and early or intermediate AMD compared to the 
standard protocols, hence may be used for early detection of the disease. In a pilot 
study, we aimed to determine whether retinal sensitivity measured under mesopic 
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illumination differed in healthy older participants with and without the AMD (CFH 
and ARMS2) risk genotypes. 
 
 MATERIALS AND METHODS 4.4
4.4.1 Participants 
One hundred and nineteen participants (58 male, 61 female) between the ages of 
19 and 85 years were recruited from volunteers at Queensland University of 
Technology (QUT) and the QUT Eye clinic. Ninety-eight participants (47M and 51F; 
age range 19 – 85 years) had no ocular disease and served as the healthy ageing 
group. Of these 98 healthy participants, 15 participants (7M and 8F; age 69.0 ± 5.6 
years) comprised the age-matched control group to the 21 participants (11M and 
10F; age 73.9 ± 6.5 years) with AMD in both eyes (AREDS grade 2 or 3) based on 
the results of two independent gradings of the fundus photographs (Age-Related Eye 
Disease Study Research Group 2001b). Where AMD was present in both eyes, the 
patients’ preferred eye was measured. Where participants had AREDS Grade 1 in 
one eye, the eye with AMD was chosen as the study eye. The number of AMD 
patients with the study eye for each grade is given in Table 4.1. Power analysis 
determined a required sample size of 10 participants (5 per group) to statistically 
detect a significant mean difference of 0.4 log contrast between mesopic and 
photopic contrast sensitivity with a power of 95%. A sample size of 19 participants 
per group was required to statistically detect a mean difference of 2 dB (1.6 % 
contrast) between high mesopic and low mesopic microperimetry with a power of 
95%. An interviewer-administered questionnaire determined visual health history, 
family history of AMD, medication use, diet and supplements use and AMD risk 
factors such as smoking. All participants underwent an ophthalmic examination, 
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which included high contrast VA (Bailey-Lovie letter chart, NVRI, Australia), colour 
vision (Lanthony D-15 desaturated, Richmond Products, Albuquerque, NM), 
tonometry (iCare TA01, Helsinki, Finland), optical coherence topography (OCT, 
Cirrus HD-OCT; Carl Zeiss Meditec, USA), ophthalmoscopy and colour fundus 
photography (CR-1, Canon, Australia). The healthy participants had normal vision 
(6/6 or better), crystalline lens opacities ≤ Grade 2 (LOCS III) (Chylack et al. 1993), 
no ocular disease and were in good general health. The AMD patients had a best 
corrected VA ≥ 6/9, crystalline lens opacities ≤ Grade 2 (LOCS III) and no history of 
ocular or systemic disease other than AMD.  
 Table 4.1: The number of AMD patients in each group classified by the study eye 
AREDS grade.  
 
 
 
 
Grade 2: n = 13 
Grade 3: n = 8 
As AMD is a multifactorial disease including environmental and genetic risk factors 
(Seddon et al. 2009), we genotyped 24 of the healthy older participants aged > 50 
years to determine whether AMD risk genotypes were a contributing factor to a 
decline in retinal function in older age. Participants were genotyped by means of 
saliva samples collected using self-collection kits (Oragene DNA self-collection kit, 
DNA Genotek Inc, Ottawa, Ontario, Canada). DNA extraction and genotyping was 
completed commercially using a restriction fragment length polymorphism (RFLP) 
AREDS Grade No. of AMD patients 
2a n = 3 
2b n = 8 
2c n = 2 
3a n = 2 
3b  n = 1 
3c n = 5 
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technique and screened for the SNPs of the complement factor H gene (CFH Y402H; 
rs1061170) and age-related maculopathy susceptibility 2 gene (ARMS2; rs10490924) 
which have both been linked to AMD (Ross et al. 2007). Participants were classified 
as high, medium or low risk depending on homozygous or heterozygous risk alleles 
for one or both SNPs (Rivera et al. 2005).  
 
Written informed consent was obtained from all participants after full explanation of 
procedures and possible risks of the study. The study was conducted in accordance 
with the requirements of the Queensland University of Technology Human Research 
Ethics Committee and the tenets of the Declaration of Helsinki.  
 
4.4.2 Visual function testing 
Contrast sensitivity was measured using a wall mounted (90 x 60 cm) Pelli-
Robson chart (Mäntyjärvi & Laitinen 2001; Pelli et al. 1988; Puell, Palomo, 
Sánchez-Ramos & Villena 2004) with 16 triplets of 4.9 × 4.9 cm letters that subtend 
3° at a 1 m viewing distance. These letters are arranged in 8 lines with two triplets 
per line. Contrast levels within each triplet are the same and contrast decreases by a 
factor of 0.15 log units in each successive triplet, reading from left to right and down 
the chart. At the manufacturer recommended 1 m test distance, the letter size 
corresponds to a spatial frequency of ~1 c/°. In clinical practice this test is 
administered under bright ambient (photopic) room illumination (> 85 lux). 
Illumination was determined at several locations within the consultation room using 
a calibrated ILT1700 photometer (International Light Technologies, Peabody, MA, 
USA). For the photopic test condition the mean room illumination was set at 85 lux; 
a dimmer switch was used to reduce the room illumination to a mean level of 1.04 
  
Mesopic Pelli-Robson contrast sensitivity and MP-1 microperimetry in healthy ageing and age-related macular 
degeneration 57 
lux for the mesopic test conditions. Binocular performance is better than monocular 
in normally sighted people due to summation (Campbell & Green 1965), however, 
normal ageing reduces binocular summation (Pardhan 1996; Ross, Clarke & Bron 
1985) and we were interested in this effect in our cohort of participants with and 
without AMD. Therefore, participants were tested binocularly under photopic and 
mesopic conditions using two Pelli-Robson charts with different letters to prevent 
memorization. Although the AMD eyes had a similar grading result in each eye 
(AREDS 2 or 3), the patients were also tested monocularly to allow for the different 
stages of disease and the results from the better eye and worse eye were therefore 
compared to the monocular results of the age-matched healthy controls.  
 
Macular sensitivity was measured monocularly using the MP-1 microperimeter 
(Nidek Technologies, Japan) (Feigl et al. 2011a; Midena, Vujosevic & Cavarzeran 
2010; Rohrschneider et al. 2008) under standard testing conditions and custom 
modified low mesopic testing conditions following established protocols 
(Rohrschneider et al. 2008). The microperimeter operates at (high) mesopic light 
levels (1.27 cd.m
-2
 background) in the upper range of rod sensitivity (CIE 1989) and 
therefore visual detection is likely to be cone dominated. We were interested to 
determine if a reduction in the luminance to 0.801 cd.m
-2
 increased the tests’ 
sensitivity to visual loss by increasing the level of rod sensitivity relative to cone 
sensitivity without excluding cone input as occurs under scotopic microperimetry 
(Nebbioso, Barbato & Pescosolido 2014). A pilot study (including 0.1, 0.2, 0.3, 0.5 
and 1 ND’s) determined that a 0.2 neutral density (ND) filter was optimal to reduce 
the background to a low mesopic luminance (0.801 cd.m
-2
) without affecting the 
real-time fundus tracking ability of the internal camera. After pupil dilation 
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(tropicamide 1% and phenylephrine 2.5%), microperimetry was performed in the 
right eye in healthy participants and in the eye with better VA in AMD patients. 
Participants fixated on a central red cross (1°) and the customized program randomly 
presented a Goldmann III (0.41° diameter), 200 ms white stimulus on a 1.27 cd.m
-2
 
background to 40 retinal points within 10° of the fovea. Retinal sensitivity (decibels) 
was measured using a 4-2 staircase strategy, increasing from 0 dB (maximum 
contrast required to see stimulus) in 2 dB increments, to 20 dB (minimum contrast 
required to see stimulus). This protocol ensured measurement of the entire macular 
region whilst minimising testing time and thereby reducing the effect of fatigue 
(Convento & Barbaro 2007).  
 
4.4.3 Analysis 
Statistical analyses were performed using SPSS (version 21; IBM Corporation, 
Armonk, NY, USA). Contrast sensitivity was scored under photopic and mesopic 
illumination as the lowest contrast level at which at least two of the three letters in a 
triplet was identified correctly (Pelli et al. 1988). Linear regression analysis was 
performed to determine the effect of ageing and onset of AMD on contrast sensitivity 
as measured under different illumination levels. Microperimetry data were averaged 
for each participant over the 40 tested retinal points. As AMD affects paracentral 
before central areas in early stages of the disease (Cheng & Vingrys 1993; Swann & 
Lovie-Kitchin 1991), data were also analyzed in three concentric rings at 2°, 6° and 
10° eccentricity to determine whether there is a location effect. To allow direct 
comparison of the standard microperimetry and low mesopic microperimetry data, 
the decibel values were converted to macular sensitivity (%). Linear regression 
analysis was performed to determine the effect of ageing and onset of AMD on 
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retinal sensitivity under standard and low mesopic illumination. To determine the 
effect of AMD grade on retinal sensitivity and to account for the age difference 
between age-matched controls and AMD participants, each parameter (contrast 
sensitivity and mean macular sensitivity) was evaluated using independent t-tests. A 
p-value of < 0.05 was considered statistically significant. The diagnostic value of the 
CS and microperimetry tests measured under mesopic illumination was evaluated 
using receiver operator characteristic (ROC) analysis by quantifying the difference 
between the AMD patients and age-matched control participants and reported as area 
under the curve (AUC). The effect of AMD risk genotypes on retinal sensitivity (CS 
and MP-1) in the healthy older participants was investigated and descriptive statistics 
reported.   
 
 RESULTS 4.5
4.5.1 Contrast sensitivity 
Binocular Pelli-Robson CS was completed in 73 out of 98 healthy participants 
(37M and 36F) (25 participants who completed microperimetry did not return for CS 
testing) and in 21 early and intermediate AMD patients (11M and 10F) under 
photopic and mesopic illumination (Figure 4.1). There was no significant difference 
between AMD grades for photopic CS (t [19] = 0.83, p = 0.418) or mesopic CS (t 
[15] = 0.42, p = 0.679), therefore the AMD patients were combined to increase the 
sample power. Within the healthy participants group (Panel A, Figure 4.1), there was 
a significant linear decline in binocular CS with age for both photopic (F1,72 = 29.41, 
R
2 
= 0.29, p < 0.0001, slope = -0.004 log CS per year) and mesopic (F1,72 = 23.5, R
2 
= 
0.25, p < 0.0001, slope = -0.004 log CS per year) conditions, consistent with 
previous findings (Mäntyjärvi & Laitinen 2001; Puell et al. 2004); the slopes of the 
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photopic and mesopic data were not significantly different from each other, however 
CS was lower under the mesopic illumination condition. On inclusion of the AMD 
participants (Panel B, Figure 4.1), the slope of the regression line for the mesopic 
illumination showed a further significant decline in binocular CS (F1,93 = 70.96, R
2 
= 
0.43, p < 0.0001, slope = -0.007 log CS per year) whereas it remained unchanged for 
photopic illumination (F1,93 = 57.23, R
2 
= 0.38, p < 0.0001, slope = -0.004 log CS per 
year), indicating a more pronounced visual deficit under mesopic testing.  
 
 
Figure 4.1: Photopic and mesopic Pelli-Robson contrast sensitivity as a function of 
ageing and presence of early and intermediate AMD.  
Panel A: binocular contrast sensitivity decreases with increasing age at a similar rate under 
photopic (open circles) and mesopic (closed triangles) illumination (-0.004 log CS per year). 
Panel B: On inclusion of the AMD patients (green symbols), there is a significantly steeper 
decrease in contrast sensitivity when measured under mesopic illumination (-0.007 log CS 
per year) compared to photopic illumination (-0.004 log CS per year). 
 
 
Fifteen out of 21 AMD patients (7M and 8F; age 73.9 ± 6.5 years) completed the 
monocular CS test and the mean (μ ± SD) CS of each eye (better and worse) of the 
AMD group was compared to the mean CS in the dominant eye of 15 age-matched 
healthy controls (7M and 8F; age 69.0 ± 5.6 years) (Figure 4.2). Under photopic 
conditions there was no significant difference between groups for the better eye (t 
[28] = 1.76, p = 0.09) or worse eye (t [28] = 0.88, p = 0.39). Under mesopic 
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conditions, the AMD group had significantly lower sensitivity in both the better eye 
(t [28] = 3.08, p = 0.005) and worse eye (t [28] = 3.01, p = 0.005). The ROC analysis 
showed that the AUC for AMD patients was higher with mesopic CS than photopic 
CS (mesopic AUC = 0.92; photopic AUC = 0.81) whereas the AUC for age-matched 
controls was similar for both mesopic and photopic CS conditions (mesopic AUC = 
0.70; photopic AUC = 0.66). 
 
 
Figure 4.2: Monocular contrast sensitivity in AMD and age-matched controls. 
Mean (μ ± SD) monocular (better and worse eye) contrast sensitivity in AMD patients and 
age-matched controls shows a significant decrease in contrast sensitivity for the AMD group 
under mesopic illumination (closed circles) compared to photopic (open circles) 
illumination. 
 
 
4.5.2 Microperimetry 
Microperimetry was performed in 89 out of 98 healthy participants and in 18 out 
of 21 AMD participants (9 healthy participants declined to participate and 3 AMD 
patients were unable to complete either standard or low mesopic microperimetry due 
to unstable fixation). Out of the 18 AMD patients, 15 completed both standard and 
low mesopic tests; however, 3 patients were able to complete only the standard test. 
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The relationship between mean macular sensitivity and age was therefore 
investigated in the better eye of 18 AMD patients (standard condition), 15 AMD 
patients (low mesopic condition) and the dominant eye of 89 healthy participants 
(age 19-85 years) under standard (high mesopic) and low mesopic testing conditions 
(Figure 4.3). There was no significant difference between grades for high mesopic 
microperimetry (t [13] = 0.801, p = 0.437) or low mesopic microperimetry (t [13] = 
0.862, p = 0.404). Within the healthy participants, there was a significant and linear 
decline in macular sensitivity with age for both standard (high mesopic) (F1,87 = 
42.74, R
2 
= 0.33, p < 0.0001, slope = -0.51 % contrast per year) and low mesopic 
conditions (F1,87 = 125.3, R
2 
= 0.59, p < 0.0001, slope = -0.79 % contrast per year) 
(Panel A, Figure 4.3); a greater decline was seen under low mesopic conditions. On 
inclusion of the AMD patients (Panel B, Figure 4.3), the slope of the regression line 
changed for both standard (F1,105 = 112.1, R
2 
= 0.52, p < 0.0001, slope = -0.73 % 
contrast per year) and mesopic (F1,102 = 244.5, R
2 
= 0.71, p < 0.0001, slope = -0.99 % 
contrast per year) illuminations, such that it was greater compared to the loss due to 
normal ageing. Comparison of the AMD group and age-matched controls showed 
significantly lower sensitivity for the AMD group under both high mesopic (t [28] = 
3.26, p = 0.003) and low mesopic (t [28] = 4.03, p < 0.0001) illumination.  
 
Analysis of the effect of eccentricity on macular sensitivity showed no significant 
difference between concentric rings for either of the illuminations. Analysis of the 
age difference between the age-matched controls and AMD patients showed no age 
effect. The ROC analysis showed high sensitivity and specificity for the AMD group 
under both standard and mesopic test conditions (mesopic AUC = 0.96; standard 
AUC = 0.93). The AUC for the age-matched controls was lower than the AMD 
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group but showed little difference between standard and mesopic conditions 
(mesopic AUC = 0.77; standard AUC = 0.74). 
Figure 4.3: High and low mesopic macular sensitivity as a function of ageing and 
presence of early and intermediate AMD.  
Mean (μ ± SD) macular sensitivity significantly decreases with increasing age under high 
mesopic (-0.51 % contrast per year; open circles) and low mesopic (-0.73 % contrast per 
year; closed triangles) illumination (Panel A) in healthy participants. The inclusion of the 
AMD patients (Panel B; green symbols) shows a greater decrease in mean macular 
sensitivity under both high mesopic (-0.73 % contrast per year) and low mesopic 
illumination (-0.99 % contrast per year). 
 
We examined the risk alleles for two AMD genotypes (CFH or ARMS2) separately, 
as well as for the combination of both (CFH + ARMS2) in the older healthy 
participants (n = 24). Table 4.2 outlines the grouping of older participants (age range 
50-85 years) into high, medium or low risk alleles for the combination and single 
CFH and ARMS2 genotypes.  
Table 4.2: Distribution of AMD risk genotypes with risk alleles for the older age group 
(age 50-85 years). 
Gene variant High risk  Medium risk  Low risk  
CFH + ARMS2 
CC+TT (n = 0) 
CC+GT (n = 1) 
CT+TT (n = 0) 
CC+GG (n = 3) 
CT+GT (n = 5) 
TT+TT (n = 0) 
TT+GG (n = 4) 
CT+GG (n = 5) 
TT+GT (n = 6) 
CFH  CC (n = 4) CT (n = 10) TT (n = 10) 
ARMS2 TT (n = 0) GT (n = 12) GG (n = 12) 
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Due to the small number of participants in the gene analysis, only the median and 
interquartile range (IQR) is reported. Pelli-Robson CS (Panel A, Figure 4.4) did not 
differ between high, medium and low risk genotypes under photopic (median = 1.65 
log CS; IQR = 0.08) or mesopic (median = 1.35 log CS; IQR = 0.15) illumination for 
the individual (CFH or ARMS2) or combined (CFH + ARMS2) gene variants.  MP-1 
macular sensitivity (Panel B, Figure 4.4) was similar between low and intermediate 
risk genotypes for the individual (CFH or ARMS2) and combined (CFH + ARMS2) 
gene variants under high mesopic (median = 86% contrast; IQR = 37) and low 
mesopic illumination (median = 63% contrast; IQR = 17), however, the only 
participant that had the highest risk with CFH (CC) and ARMS2 (GT) also showed 
the lowest MP-1 macular sensitivity under both the high mesopic (42 % contrast) and 
low mesopic illumination (54 % contrast). 
 
 
Figure 4.4: Retinal sensitivity for AMD risk genotypes under high and low illumination  
Comparison between AMD risk genotypes in healthy older participants for photopic (open) 
and mesopic (pattern) Pelli-Robson CS (Panel A) and macular sensitivity (Panel B) shows no 
difference between high, medium and low risk genotypes. The combined high risk genotype 
CFH (CC) and ARMS2 (GT) is only present in one participant and shows decreased MP-1 
macular sensitivity under high mesopic and low mesopic illumination (Panel B). 
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 DISCUSSION 4.6
We demonstrate that mesopic Pelli-Robson contrast sensitivity detects a 
statistically significant reduction in contrast sensitivity in AMD that can be 
differentiated from normal ageing that is not differentiated under standard photopic 
test conditions (Figure 4.1; Figure 4.2). In comparison to the mesopic Pelli-Robson 
test; there is no further improvement in the sensitivity of the MP-1 microperimeter 
between the standard (high mesopic) and low mesopic test conditions (Figure 4.3).  
 
Advanced age is a main risk factor of AMD; therefore any reduction in retinal 
function due to normal ageing must be differentiated from that associated with AMD. 
While photopic VA and CS decrease gradually with age (Elliot, Yang & Whitaker 
1995; Mäntyjärvi & Laitinen 2001), less is known about mesopic vision and its 
relationship with age-related photopic decline in healthy participants and in patients 
with AMD (Feigl et al. 2011a; Petzold & Plant 2006; Puell et al. 2012; Puell et al. 
2004). Mesopic tests that assess rods and cones under the same illumination 
conditions are thought to be more sensitive to early vision loss in AMD because rods 
are first affected (Curcio et al. 1996) and a paracrine relationship between rods and 
cones (Mohand-Said et al. 2001) suggests that rod dysfunction consequently affects 
cone function. A recent study demonstrates that high contrast, low luminance VA 
(achieved by adding ND filters rather than by simply adjusting the illumination of the 
consultation room) was not more sensitive to early changes in AMD compared to 
high contrast, high luminance VA (Wu et al. 2014). Puell et al (2012) showed that 
AMD patients have worse mesopic VA at both high and low contrast. Contrast 
sensitivity, however, is a more sensitive measure of central visual function than VA 
because it measures a progressive change in luminance differences between test letter 
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and surround rather than under constant contrast conditions (Owsley 2003). The 
measurement of mesopic CS may therefore be more sensitive to changes in AMD 
than mesopic VA. Photopic CS is reduced in AMD patients compared to healthy 
controls using letter by letter scoring (Feigl et al. 2004), as opposed to this study 
where triplet scoring was used. Triplet scoring however, is recommended based on 
maintaining a high level of accuracy while still providing a sensitive measure of 
contrast (Pelli et al. 1988). A significant difference in photopic CS may have been 
evident had we used letter by letter scoring, however, this method can result in high 
susceptibility to misreporting errors (Pelli et al. 1988).  
 
MP-1 sensitivity is significantly reduced in AMD compared to age-matched healthy 
controls (Figure 4.3); lowering the background luminance of the standard (high 
mesopic) microperimeter to low mesopic levels did not provide any additional 
advantage in detecting deficits earlier in our study. Given that AMD deficits occur 
parafoveally in early stages of the disease (Cheng & Vingrys 1993; Swann & Lovie-
Kitchin 1991), we conducted an analysis of the concentric rings but this did not 
provide additional information. Scotopic microperimetry has shown a higher 
sensitivity to retinal dysfunction compared with standard microperimetry in patients 
with drusen (Nebbioso et al. 2014), possibly due to increased sensitivity to early rod 
photoreceptor loss in AMD. This and our study confirm the already high sensitivity 
of microperimetry in detecting early stages of disease (AREDS 2 and 3) (Midena et 
al. 2007).  
 
We did not detect any difference in Pelli-Robson CS or MP-1 macular sensitivity 
between the different AMD risk genotype groups under photopic or mesopic 
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illumination in our older healthy participants as previously detected with 
measurement of the mesopic CFF (Feigl et al. 2011a). While the application of a 
flickering stimulus to measure the CFF to increase the metabolic demand may be 
more sensitive to the presence of visual dysfunction in persons with high risk 
genotypes, both the CS and MP-1 tests may not provide sufficient changes to the 
metabolic demand required to detect the small changes in retinal function determined 
by a genetic predisposition. In our cohort there was only one patient with high risk 
gene variants for both CFH and ARMS2, and this person showed substantially 
decreased macular sensitivity (Figure 4.4), but a larger group of patients with the 
combined high risk genotypes is needed to confirm this hypothesis.  
 
In conclusion, mesopic CS can be simply measured by using a readily available chart 
and dimming the room illumination and, together with genetic testing, may identify 
susceptibility to AMD. Further reduction of the illumination of standard 
microperimetry may allow better differentiation of deficits due to a reduced ceiling 
effect. Mesopic CS can detect visual loss not observed using the standard photopic 
CS protocol in early and intermediate AMD and may be a preferred option to 
microperimetry, which is more time demanding. 
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 Melanopsin mediated post-Chapter 5:
illumination pupil response in early age-
related macular degeneration 
 ABSTRACT 5.1
5.1.1 Purpose 
To determine whether melanopsin expressing intrinsically photosensitive Retinal 
Ganglion Cell (ipRGC) inputs to the pupil light reflex (PLR) are affected in early age-
related macular degeneration (AMD).  
5.1.2 Methods  
The PLR was measured in 40 participants (20 early AMD and 20 age-matched 
controls) using a custom-built Maxwellian-view pupillometer. Sinusoidal stimuli (0.5 
Hz, 11.9 s duration, 35.6° diameter) were presented to the study eye and the 
consensual pupil response was measured for stimuli with high melanopsin excitation 
(464nm; blue) and with low melanopsin excitation (638 nm; red) that biased activation 
to the outer retina. Two melanopsin PLR metrics were quantified: the Phase 
Amplitude Percentage (PAP) during the sinusoidal stimulus presentation and the Post-
Illumination Pupil Response (PIPR). The PLR during stimulus presentation was 
analyzed using latency to constriction, transient pupil response and maximum pupil 
constriction metrics. Diagnostic accuracy was evaluated using receiver operating 
characteristic (ROC) curves. 
5.1.3 Results 
The blue PIPR was significantly less sustained in the early AMD group (p<0.001). 
The red PIPR was not significantly different between groups (p>0.05). The PAP and 
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blue stimulus constriction amplitude were significantly lower in the early AMD group 
(p < 0.05). There was no significant difference between groups in the latency or 
transient amplitude for both stimuli (p>0.05). ROC analysis showed excellent 
diagnostic accuracy for the blue PIPR metrics (AUC>0.9).   
5.1.4 Conclusions 
This is the initial report that the melanopsin controlled PIPR is dysfunctional in 
early AMD. The non-invasive, objective measurement of the ipRGC controlled PIPR 
has excellent diagnostic accuracy for early AMD. 
 KEYWORDS  5.2
Melanopsin, intrinsically photosensitive Retinal Ganglion Cells (ipRGCs), pupil 
light reflex, post-illumination pupil response 
 
 INTRODUCTION  5.3
Melanopsin-expressing intrinsically photosensitive Retinal Ganglion Cells 
(ipRGCs) form the recently identified third photoreceptor class in the eye and have 
important non-image forming functions including mediation of the pupillary response 
(Gamlin et al. 2007; Lucas et al. 2001a) and photoentrainment of circadian rhythm 
(Berson et al. 2002; Hattar et al. 2002; Markwell et al. 2010; Panda et al. 2002). Their 
cell bodies are primarily located in the ganglion cell layer, with a small number 
displaced to the inner nuclear layer (Provencio et al. 2000). While ipRGC physiology 
and function has been studied in both nocturnal rodents (Berson, Castrucci & 
Provencio 2010; Hattar et al. 2002) and primates (Dacey et al. 2005; Jusuf et al. 2007), 
research is increasingly focusing on their roles in diurnal humans and in particular in 
diseased eyes, with preliminary reports for potential ipRGC dysfunction in age-related 
macular degeneration (AMD) (Feigl & Zele 2014). 
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Psychophysical and electrophysiological studies are well established for measuring 
functional deficits of rods and cones in different stages of AMD (Cheng & Vingrys 
1993; Dimitrov, Guymer, Zele, Anderson & Vingrys 2008; Dimitrov et al. 2011; Feigl 
et al. 2004, 2005a; Lovie-Kitchin & Feigl 2005; Mayer et al. 1992; Owsley et al. 
2001) however, the effect of AMD on ipRGC function is unknown. The Pupil Light 
Reflex (PLR) provides a rapid, objective, non-invasive measure of both inner (ipRGC) 
and outer (rod and cone) retinal function (Adhikari et al. 2015b; Feigl & Zele 2014; 
Herbst, Sander, Milea, Lund-Andersen & Kawasaki 2011; Kankipati et al. 2010; 
Kardon et al. 2009; Markwell et al. 2010; McDougal & Gamlin 2010; Park et al. 
2011). Following onset of an incremental light pulse, the initial PLR is mediated by 
the outer retina (Güler et al. 2008; McDougal & Gamlin 2010) with increasing 
melanopsin input with longer stimulus durations (McDougal & Gamlin 2010), while 
ipRGCs control the Post-Illumination Pupil Response (PIPR), the sustained pupil 
constriction after light offset (Adhikari et al. 2015b; Feigl & Zele 2014; Gamlin et al. 
2007). Recently it was demonstrated that for sinusoidal lights with high melanopsin 
excitation, the peak-to-trough amplitude of the phasic PLR during flicker stimulation 
was suppressed compared to lights with low melanopsin excitation (Feigl & Zele 
2014; Joyce et al. 2015). This suppression is analysed using a Phase Amplitude 
Percentage (PAP) metric to provide a direct marker of melanopsin inputs to the pupil 
during light stimulation (Feigl & Zele 2014). 
 
IpRGC function has been measured using the PIPR in diabetic patients without 
diabetic retinopathy (Feigl et al. 2012b), glaucoma (Feigl et al. 2011b; Gracitelli et al. 
2014; Kankipati et al. 2011), retinitis pigmentosa (Kardon et al. 2011; Kawasaki, 
Crippa, Kardon, Leon & Hamel 2012; Markwell et al. 2010), Leber’s hereditary optic 
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neuropathy (Kawasaki, Herbst, Sander & Milea 2010) and retinal dystrophy (Vugler, 
Semo, Joseph & Jeffery 2008). In AMD, the PLR has been used as a measure of outer 
retinal function (Asakawa, Ishikawa, Ichibe & Shimizu 2014; Brozou et al. 2009; 
Feigl & Zele 2014; Nakayama, Nowak, Ishikawa, Asakawa & Ichibe 2014; Rosli et al. 
2012; Sabeti et al. 2013; Sabeti et al. 2011) and demonstrates a longer latency to 
constriction and reduction in maximum pupil constriction amplitude. However, these 
studies were not designed to measure ipRGC function in AMD. Pathological changes 
in AMD first occur in the paracentral retina (Swann & Lovie-Kitchin 1991) where 
ipRGCs have their highest density (Dacey et al. 2005; Jusuf et al. 2007), which may 
make ipRGCs susceptible during early disease. In advanced stages of the disease, there 
is ~50% loss of inner retinal ganglion cells (Medeiros & Curcio 2001). Although 
ipRGCs are robust in early stages of diseases affecting the optic nerve (Cui et al. 
2015), it is still not known how ipRGCs are affected in patients with early AMD, with 
our group showing the first evidence of ipRGC alteration (Feigl & Zele 2014). The 
primary purpose of this study is to measure the effect of early AMD on inner retinal 
contributions to the PLR using the PIPR metric and to use a novel sinusoidal stimulus 
paradigm that reflects inner retina (ipRGCs) and outer retina (rods and cones) 
interactions in the phasic pupil response (Feigl & Zele 2014).  
 METHODS 5.4
5.4.1 Participants 
Forty participants (20 female, 20 male) were recruited from the Queensland 
University of Technology (QUT) eye clinic. Twenty participants (10F and 10M; age 
69.3 ± 5.5 years) were healthy controls and 20 were participants with early AMD (10F 
and 10M; age 72.9 ± 6.3 years) who had either AREDS grade 2 or grade 3 AMD 
(Table 5.1) based on the results of two independent gradings of the fundus 
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photographs (Age-Related Eye Disease Study Research Group 2001b). Where early 
AMD was present in both eyes, the patients preferred eye was measured. Where 
participants had grade 1 in one eye, the eye with early AMD was chosen as the study 
eye. Participants with Grade 4 (advanced) in either eye were excluded. All participants 
underwent an ophthalmic examination, which included visual acuity (Bailey Lovie), 
ophthalmoscopy, colour vision (Lanthony D-15 desaturated), tonometry (iCare TA01, 
Finland), optical coherence topography (OCT, Cirrus HD-OCT; Carl Zeiss Meditec, 
USA) and colour fundus photography (CR-1, Canon, Australia). The control group 
had normal vision (6/6 or better), crystalline lens opacities ≤ Grade 2 (Age-Related 
Eye Disease Study Research Group 2001a), no ocular disease and were in good 
general health. The early AMD group had a best corrected visual acuity ≥ 6/9 in the 
study eye, crystalline lens opacities ≤  Grade 2 (Age-Related Eye Disease Study 
Research Group 2001a) and no history of ocular or systemic disease other than AMD. 
No participant had taken any medication that could affect the pupil response. Written 
informed consent was obtained from all participants and the study was conducted in 
accordance with the requirements of the Queensland University of Technology Human 
Research Ethics Committee and the tenets of the Declaration of Helsinki. 
Table 5.1: Grading of each eye for all AMD patients according to AREDS grading scale 
with the study eye in bold. 
 
Grade   Grade 
Px No.      RE LE  Px No.      RE LE 
1 2b 2b  11 3a 3c 
2 3d 2a  12 3a 3a 
3 2c 2b  13 3c 3c 
4 2b 2b  14 2a 2b 
5 1 2c  15 2b 2b 
6 3d 2b  16 2c 1 
7 2b 2b  17 2a 3 
8 2b 2b  18 3c 3c 
9 2b 2b  19 3a 3d 
10 3a 3c  20 3c 3c 
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5.4.2 Pupillometer 
Sinusoidal stimuli (0.5 Hz, 11.9 s duration) were presented using a custom built, 
extended Maxwellian view pupillometer (Feigl & Zele 2014; Kankipati et al. 2010) 
comprising narrowband LED light sources (638 nm and 464 nm) imaged in the pupil 
plane via two Fresnel lenses (100 mm diameter, 127 mm and 70 mm focal lengths; 
Edmund Optics, Singapore) and a 5˚ light shaping diffuser (Physical Optics Corp., 
California, USA) to provide a 35.6˚ diameter light stimulus (retinal image diameter: 
15.4 mm) (Adhikari et al. 2015b) . The consensual pupil light reflex was recorded 
under infrared LED illumination (max = 851 nm) using a Pixelink camera (IEEE-1394, 
PL-B741 Fire Wire; 640 x 480 pixels; 60 frames/s) through a telecentric lens 
(Computar 2/3ʺ 55 mm and 2 x extender C-Mount) (Adhikari et al. 2015b). 
Customized Matlab software (version 7.12.0, Mathworks, Massachusetts, USA) 
controlled stimulus presentation and timing. Blink artefacts were identified and 
extracted during software analysis of pupil recordings by a customized algorithm 
using linear interpolation (Adhikari et al. 2015b). The spectral outputs of the LED 
stimuli were measured with a Spectroradiometer (StellarNet, Florida, USA) and 
irradiance was calibrated with an ILT1700 Research Radiometer (International Light 
Technologies, Massachusetts, USA).  
 
5.4.3 Procedure 
After an initial ophthalmic assessment, Tropicamide 1% (Minims, Chauvin 
Pharmaceuticals Ltd., England) was instilled in the study eye and a 15 minute dark 
adaptation period commenced in a darkened (< 1 lux) laboratory prior to pupil 
recordings. The participant was then aligned in the pupillometer in Maxwellian view 
with the head held steady by temple bars and a head brace. The participant was 
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instructed to look straight ahead in the dark as if fixating a distant object and fixation 
was monitored with the IR camera. The consensual pupil reflex was measured in 
response to short wavelength light (464nm) with high melanopsin excitation (Berson 
et al. 2002; Gamlin et al. 2007; Kardon et al. 2009; Park et al. 2011) and to long 
wavelength light (638 nm) that biased activation to the outer retina (Park et al. 2011) 
and provided a control. The corneal irradiance of the long and short wavelength 
stimuli was 15.1 log quanta.cm
-2
.s
-1
. This provided a retinal irradiance of 14.5 log 
quanta.cm
-2
.s
-1
 for short wavelength and 14.9 log quanta.cm
-2
.s
-1 
for long wavelength 
light (van de Kraats & van Norren 2007). A single pupil recording comprised a 10 s 
pre-stimulus period, presentation of an 11.9 s sinusoidal stimulus and a 40 s post-
illumination period. Two repeats for each stimulus (464 nm and 638 nm) were 
recorded with a five minute dark adaptation period between trials (Joyce et al. 2015). 
The short and long wavelength stimuli were alternated in all sessions with the long 
wavelength light always presented first to control for the effect of melanopsin 
bistability (Mure, Rieux, Hattar & Cooper 2007). All measurements were completed 
during a similar time of day to control for the effect of circadian variation on the PIPR 
(Zele et al. 2011).  
 
5.4.4 Analysis 
Figure 5.1 shows the average pupil light reflex of 20 control participants with no 
retinal abnormalities in response to an 11.9 s, 0.5 Hz sinewave stimulus of long (638 
nm; red) or short (464 nm; blue) wavelength light. The PLR was described with linear 
and exponential models (Feigl & Zele 2014; Zele et al. 2011) and analyzed according 
to protocols defined by Adhikari, Zele and Feigl (2015b). To control for individual 
differences in resting pupil diameter, all data are reported as a percentage of the resting 
baseline pupil diameter (average pupil diameter during 10 s pre-stimulus period). The 
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PLR during stimulus presentation was quantified using the transient pupil response 
(maximum constriction at 500 ms after stimulus onset), latency to constriction (time 
taken to constrict 1% of baseline pupil diameter) and constriction amplitude 
(minimum pupil diameter during presentation of light stimulus); a smaller percentage 
value indicates larger constriction amplitude (Figure 5.1). The PIPR was quantified at 
6 s (sustained pupil constriction at six seconds after light stimulus offset) and plateau 
(derived from the exponential model fit to the PIPR). The Phase Amplitude Percentage 
(PAP) (Feigl & Zele 2014) was calculated as the percentage difference in peak-to-
trough amplitude between the phasic pupil response during light stimulation to the 
long and short wavelength sinewave stimuli. 
 
Figure 5.1: Graphic representation of the pupil light reflex (PLR) to long and short 
wavelength stimuli in healthy controls.  
The average pupil light reflex of 20 control participants with no retinal abnormalities to an 
11.9 second, 0.5 Hz sinewave stimulus of long (638 nm; red) or short (464 nm; blue) 
wavelength light. Data are presented as a percentage of the baseline pupil diameter (horizontal 
dashed line). The 6 s PIPR (vertical dashed line) measures the pupil diameter six seconds after 
light offset while the plateau PIPR (horizontal dotted line) shows the plateau of the 
exponential fit to the post-stimulus pupil diameter. The PAP is determined by the average 
peak to trough amplitude of the red and blue sinewave pupil response during stimulus 
presentation. 
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Statistical analyses were performed using commercially available statistical software 
(IBM SPSS, version 21; IBM Corporation, Armonk, NY, USA). Parametric tests were 
applied to all data that passed the Kolmogorov-Smirnov test of normality. Each metric 
was evaluated by comparing red and blue stimulus responses within and between 
groups using repeated measures ANOVA and appropriate post-hoc analysis was 
performed when significant effects occurred. The latency to constriction was not 
normally distributed and an independent samples Mann-Whitney U test was used to 
compare between groups. The PAP was evaluated using independent samples t-test. A 
p-value of < 0.05 was considered statistically significant. The diagnostic accuracy of 
the PIPR metrics in determining early AMD was evaluated using receiver operator 
characteristic (ROC) analysis by quantifying the difference between the AMD patients 
and control participants.  
 
 RESULTS 5.5
Figure 5.2 shows the mean PLR and 95% confidence limits in response to long and 
short wavelength stimuli for the early AMD group compared to the healthy controls. 
Table 5.2 gives the PLR metrics for the early AMD group and control group. The 
AMD patients with AREDS grade 2 and grade 3 were not significantly different on 
any PLR metric and therefore the AMD data were pooled for comparison with the 
control group. 
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Figure 5.2: Average pupil light reflex (PLR) to long and short wavelength stimuli in 
early AMD patients compared to healthy controls.  
The average pupil light reflex to long (panel A; red) and short (panel B; blue) wavelength light 
of early AMD patients compared to healthy controls. Panel A shows the upper and lower 95% 
confidence limits for the healthy controls (shaded) and the mean response for the early AMD 
group (solid line). Panel B shows the confidence limits (shaded) and mean response (solid 
line) for both control and early AMD groups. The sustained response to blue light, measured 
at 6 s post-stimulus (vertical line), is significantly reduced in the early AMD group. 
 
Table 5.2: Pupil light reflex (PLR) metrics (μ ± σ) in healthy controls and patients with 
early age-related macular degeneration.  
The PLR to the blue stimulus was significantly different between groups for the 6 s 
PIPR (F 1, 39 = 64.56, p < 0.0001; Figure 5.3A), plateau PIPR (F 1, 39 = 33.78, p < 
0.0001; Figure 5.3B) and maximum constriction (F 1, 39 = 8.69, p = 0.005; Figure 5.4C) 
where the amplitude was significantly less for the early AMD group compared to the 
control group. There was no significant difference between groups in the transient 
 Blue stimulus  Red stimulus 
 AMD Control AMD Control 
Latency to constriction 
(ms) 
209.6 ± 88.4 211.4 ± 89.1 219.4 ± 83.1 217.5 ± 87.7 
Transient pupil response 
(%) 
20.7 ± 8.4 23.4 ± 9.4 18.4 ± 7.3 20.7 ± 7.3 
Maximum constriction 
(%) 
42.9 ± 5.3 * 38.7 ± 3.3 47.8 ± 5.1 45.1 ± 3.9 
6 s PIPR (%) 80.1 ± 6.4 * 63.0 ± 7.3 90.0 ± 4.2 87.5 ± 4.1 
Plateau PIPR (%) 92.0 ± 4.6 * 75.6 ± 11.7 96.5 ± 4.9 96.9 ± 3.3 
* p < 0.05    
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pupil response (F 1, 39 = 0.89, p = 0.351; Figure 5.4A) or latency to constriction (p = 
0.947; Figure 5.4B) for the blue stimulus. The PLR to the red stimulus was not 
significantly different between groups for any metric (p > 0.05). There was a 
significant difference (p < 0.05) between the red and blue stimulus response for all 
metrics except for latency to constriction (p > 0.05). Analysis of the PAP (Figure 
5.4D) showed a significantly lower average percentage in the early AMD group (29.5 
± 9.4 %) compared to the control group (38.4 ± 11.5 %; t (38) = 2.375, p = 0.023). The 
slope of the linear regression of the 6 s PIPR amplitude as a function of age was not 
significantly different from zero indicating that there was no effect of age on the PIPR 
(R
2
 = 0.113, F1,19 = 2.291, p = 0.147). There was no significant relationship between 
visual acuity and the PIPR metrics. The ROC analysis showed that the blue stimulus 
had a larger AUC for both the 6 s PIPR (AUC = 0.963, p < 0.001) and plateau PIPR 
metric (AUC = 0.928, p <0.001) compared to the red control stimulus (6 s: AUC = 
0.660, p = 0.083; plateau: AUC = 0.401, p = 0.298) (Figure 5.5). 
Figure 5.3: Post-illumination pupil response to red and blue stimuli in control and early 
AMD patients.  
The post-illumination pupil response to long wavelength (red) and short wavelength (blue) 
stimuli measured at 6 s after stimulus offset (panel A) and at the plateau of the exponential fit 
to the pupil diameter (panel B). The amplitude is expressed as a percentage of the average pre-
stimulus pupil diameter (baseline). The pupil response was compared between the control 
group (unfilled) and early AMD group (pattern filled). There was a significant difference in 
pupil response to the blue stimulus between groups for both 6 s and plateau PIPR metrics with 
no difference between groups for the red stimulus. 
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Figure 5.4: Average pupil light reflex metrics to red and blue stimuli for the control 
group and early AMD group.  
Each panel compares the PLR during presentation of red or blue stimuli for the control 
(unfilled) and early AMD (patterned fill) groups. The transient response (panel A) and 
maximum pupil constriction (panel C) are expressed as a percentage of the baseline pupil 
diameter while latency to constriction (panel B) is given in milliseconds (ms). The phase 
amplitude percentage (PAP) (panel D) is expressed as the percentage difference in peak-to-
trough amplitude between the phasic response to long and short wavelength sinewave stimuli. 
Both maximum constriction to the blue stimulus and PAP are significantly reduced in the 
AMD group compared to the control group. There is no significant difference in transient 
response or latency to constriction between groups for red and blue stimuli. 
 
 
Figure 5.5: Receiver Operating Characteristic (ROC) curves for blue and red stimulus 
conditions for the 6s and plateau PIPR metrics.  
The sensitivity (true positive rate) is plotted as a function of specificity (false positive rate) for 
6 s (panel A) and plateau (panel B) PIPR measurements. The blue stimulus (blue line) shows a 
significantly higher sensitivity and specificity with a larger AUC compared to the red stimulus 
(red line) for both metrics.  
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 DISCUSSION 5.6
This is the initial demonstration of a significantly reduced post-illumination pupil 
response in persons with early age related macular degeneration. These findings 
indicate that intrinsic ipRGC inputs to the pupil control pathway are altered in early 
AMD and the pupillometric measurement of the PIPR has excellent (AUC > 0.90) 
diagnostic accuracy for early AMD. By comparison, pupil parameters reflecting outer 
retinal contributions to the PLR (transient and latency) (Dacey et al. 2005; Feigl & 
Zele 2014; Güler et al. 2008) were not significantly affected. However, the large 
stimuli used in this study were selected to optimize ipRGC activation (Feigl & Zele 
2014) and would therefore be less sensitive to the presence of small, localized outer 
retinal deficits as can occur due to drusen (Feigl et al. 2005b; Johnson et al. 2003). 
 
The exact pathomechanisms in AMD are unclear, with known loss of conventional 
retinal ganglion cells (RGC) in advanced stages of AMD (Medeiros & Curcio 2001); 
previous histological studies did not study ipRGCs as they have been only recently 
discovered (Provencio et al. 2000). The relative numbers of different subtypes of 
ipRGCs may vary between species. There are at least five ipRGC subtypes (M1 to 
M5) that have been identified in transgenic mouse models based on their dendritic 
stratification that varies across the outer and inner laminae of the inner plexiform layer 
(IPL) (Jusuf et al. 2007). IpRGC dendrites express melanopsin and have comparable 
photon capture to the soma (Do et al. 2009) while also receiving synapses from bipolar 
and amacrine cells for signalling between outer and inner retina (Belenky, Smeraski, 
Provencio, Sollars & Pickard 2003; Jusuf et al. 2007; Østergaard, Hannibal & 
Fahrenkrug 2007). There is evidence of at least three ipRGC subtypes in primates 
(Dacey et al. 2005; Do & Yau 2010) but it is unknown how these different subtypes 
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are affected by retinal and optic nerve disease. In rodent studies of retinal disease, 
Royal College of Surgeons (RCS) dystrophic rats and P23H transgenic rats were used 
to investigate melanopsin cell function in retinitis pigmentosa (RP) (Esquiva, Lax & 
Cuenca 2013; Vugler et al. 2008). One study showed that some ipRGCs were lost with 
disease progression while a significant number of ipRGCs survived into advanced 
stages of degeneration in the far peripheral retina (Vugler et al. 2008). A second study 
showed progressive loss in density, cell integrity and dendritic arborisation of ipRGCs 
in advanced stages of RP (Esquiva et al. 2013) consistent with initial findings of 
ipRGC dysfunction in advanced AMD (Feigl & Zele 2014). A number of rodent (de 
Sevilla Müller, Sargoy, Rodriguez & Brecha 2014; Li et al. 2006; Robinson & 
Madison 2004) and human (Kawasaki, Collomb, Léon & Münch 2014; La Morgia et 
al. 2010; Zhou, Davis, Spitze & Lee 2014) studies show that ipRGCs are more 
resistant compared to conventional retinal ganglion cells in optic nerve disease and a 
recent study in a rat model showed that density and dendritic arborization does not 
change with age (García-Ayuso et al. 2015). An example of this resistance to damage 
is shown in a study in patients with glaucoma that demonstrated the PIPR in patients 
with early glaucoma was similar to controls (Feigl et al. 2011b), but lower in patients 
with advanced glaucoma (Feigl et al. 2011b; Kankipati et al. 2011). In patients with 
Leber’s hereditary optic neuropathy (LHON), the sustained pupil response to blue 
light in the affected eye was similar to that in the healthy eye, suggesting a resistance 
to the intracellular metabolic disorder affecting the optic nerve caused by a genetic 
defect (Kawasaki et al. 2010; Moura et al. 2013). This is confirmed in a histological 
study of LHON that showed relative sparing of ipRGCs compared to other retinal 
ganglion cells (La Morgia et al. 2010). Whilst remaining robust to early changes in 
diseases affecting the optic nerve or peripheral retina (Cui et al. 2015), we hypothesize 
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that ipRGCs may be more vulnerable in diseases affecting the central retina such as 
AMD (Swann & Lovie-Kitchin 1991). No histological study has investigated ipRGC 
distribution and potential loss in AMD and our research findings suggest that due to 
their restricted number and paracentral location (Dacey et al. 2005), ipRGC damage 
may become manifest early in the condition.  
 
Previous studies of the pupil light reflex in AMD focused on the latency to pupil 
constriction, transient pupil response and maximum pupil constriction which is largely 
controlled by the outer retina (Asakawa et al. 2014; Brozou et al. 2009; Rosli et al. 
2012; Sabeti et al. 2013; Sabeti et al. 2011), however these studies included patients 
with advanced exudative AMD and the deficit is expected to be larger in later disease 
stages. Using multifocal pupillography, Sabeti et al (2014) found reduced pupil 
responses in patients with early AMD, however their pupil paradigm is not designed to 
measure ipRGC function. While outer retinal deficits may have been manifest in the 
patients with early AMD, our testing conditions were primarily aimed towards 
optimum ipRGC isolation. Smaller stimuli (Feigl 2009) with retinal irradiance below 
melanopsin threshold (Barrionuevo et al. 2014; Kardon et al. 2009; Markwell et al. 
2010; Rosli et al. 2012) can be useful to also detect deficits in rod and cone function.  
 
A number of metrics have been used to define ipRGC response, namely redilation 
velocity (Feigl et al. 2011b; Zele et al. 2011), 6 s PIPR (Park et al. 2011), plateau PIPR 
(Gamlin et al. 2007; Markwell et al. 2010) and area under curve (AUC) (Herbst et al. 
2011). In this study, we used the 6 s and plateau PIPR metrics to measure ipRGC 
controlled PIPR following a recent study by Adhikari et al (2015b) who demonstrated 
that these metrics show the lowest coefficient of variation for inter and intra-individual 
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measurements. The newly defined PAP metric (Feigl & Zele 2014) that uses the 
phasic response during light stimulation may be also beneficial in measuring inner and 
outer retinal interactions. It is thought that the peak-to-trough amplitude for the short 
wavelength stimulus is lower than that of the long wavelength stimulus due to the 
contribution of ipRGCs to maintain pupil constriction when stimuli have high 
melanopsin excitation (Feigl & Zele 2014; Güler et al. 2008; McDougal & Gamlin 
2010); we hypothesise that if there is ipRGC loss or dysfunction in retinal disease, the 
capacity of ipRGCs to maintain pupil constriction during light stimulation will be 
reduced and result in a larger outer retinal phasic pupil response such that the phasic 
pupil response to the stimuli with high and low melanopsin excitation (e.g. blue and 
red lights) become more similar (i.e. a lower PAP). Hence, the lower PAP result in the 
early AMD group compared to the healthy controls may indicate the onset of altered 
inner and outer retinal interactions. It is known for psychophysical studies that rod-
cone interactions measured under mesopic light levels may be an early marker of 
dysfunction in people with high risk genotype for AMD (Feigl et al. 2011a). The 
differences in PIPR shown in this study are unlikely to be due to lens attenuation as 
participants were age-matched and those with lens grading above grade 2 were 
excluded, providing a true reflection of differences in inner retinal melanopsin 
function.  
 
In conclusion, this is the initial demonstration of an alteration of ipRGC function as 
measured via the PIPR in early AMD. IpRGCs may be more vulnerable to disease 
affecting the central retina as opposed to those affecting the peripheral retina or optic 
nerve. Given that the PIPR is affected in early AMD and in glaucoma (Feigl et al. 
2011b; Feigl & Zele 2014) but not in for example Leber’s hereditary optic neuropathy 
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(Kawasaki et al. 2010), these differences in the ipRGCs mediated pupil responses may 
help to provide further insight into the disease pathomechanisms. The PAP findings 
may be a result of altered signaling between inner and outer retina (Feigl & Zele 
2014). Histological studies are required for better understanding of pathophysiological 
processes involving ipRGCs in AMD. This study demonstrates that pupillometry 
provides a rapid, non-invasive means of measuring the pupil response to quantify 
ipRGC function in early stages of AMD. The pupillometry paradigms introduced here 
have excellent diagnostic accuracy and may also be useful in monitoring disease 
progression (Feigl & Zele 2014). 
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 Intrinsically photosensitive Chapter 6:
retinal ganglion cell function, sleep efficiency 
and depression in advanced age-related 
macular degeneration 
 ABSTRACT 6.1
6.1.1 Purpose 
Melanopsin expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGC) 
input to multiple brain regions including those for pupil control, circadian rhythms, 
sleep and mood regulation. Here we measured ipRGC function and its relationship to 
sleep quality and depression in patients with advanced age-related macular 
degeneration (AMD). 
 
6.1.2 Methods 
The melanopsin mediated post-illumination pupil response (PIPR) was measured in 
53 patients with advanced AMD (age 78.8 ± 8.8 years) and in 20 healthy controls (age 
72.5 ± 3.3 years). Sleep quality and efficiency was assessed using the Pittsburgh Sleep 
Quality Index (PSQI). Risk of depression was determined using the Centre for 
Epidemiologic Studies Depression (CES-D) questionnaire.  
  
6.1.3 Results 
The group with AMD showed significantly reduced pupil constrictions (p = 0.039); 
PIPR amplitudes (p = 0.003); global sleep scores (p = 0.01) and higher levels of 
depression (p < 0.001) than the control group. There was a significant correlation 
between the PIPR amplitude and global sleep score in the AMD group (p = 0.01). The 
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PIPR amplitude significantly correlated with sleep efficiency (p = 0.008; regression; p 
= 0.01, R
2
 = 0.13), but not sleep quality (p = 0.23) in the AMD group. There was no 
correlation between PIPR and depression scores. 
 
6.1.4 Conclusions 
IpRGC dysfunction in advanced AMD contributes to the observed reduction in 
sleep efficiency. The correlation between the melanopsin mediated PIPR and sleep 
may indicate reduced photic input to the suprachiasmatic nucleus (SCN) and 
ventrolateral preoptic area due to ipRGC dysfunction in AMD.   
 
 KEY WORDS 6.2
Intrinsically photosensitive Retinal Ganglion Cells (ipRGCs), pupil light reflex, 
post-illumination pupil response, sleep, depression  
 
 INTRODUCTION 6.3
Melanopsin expressing intrinsically photosensitive Retinal Ganglion Cells 
(ipRGCs) are dysfunctional in various retinal and optic nerve diseases (Feigl et al. 
2011b; Gracitelli et al. 2014; Kankipati et al. 2011; Kardon et al. 2011), including age-
related macular degeneration (AMD) (Feigl & Zele 2014; Maynard, Zele & Feigl 
2015). Non-image forming functions of these cells include signalling irradiance 
information for synchronising the circadian body clock to the solar day (Berson et al. 
2002) thus mediating photoentrainment through projections to the suprachiasmatic 
nucleus (SCN) (Chen, Badea & Hattar 2011; Zele et al. 2011) and sleep induction 
through activation of the ventrolateral preoptic area (Gooley, Lu, Fischer & Saper 
2003; Hattar et al. 2002). IpRGC dysfunction could therefore alter sleep-wake cycles 
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and affect sleep quality. IpRGCs also signal to the olivary pretectal nucleus (OPN) for 
mediation of the pupil light reflex (PLR) (Gamlin et al. 2007; Kawasaki & Kardon 
2007) and in particular the post-illumination pupil response (PIPR) (Adhikari et al. 
2016a; Gamlin et al. 2007; Kawasaki & Kardon 2007; Markwell et al. 2010), which is 
an emerging method for the direct assessment of ipRGC function in healthy and 
diseased eyes and in persons with chronobiological disorders (Feigl & Zele 2014; 
Feigl et al. 2012b; Gamlin et al. 2007; Gracitelli et al. 2016; Gracitelli et al. 2014; 
Gracitelli et al. 2015; Kawasaki & Kardon 2007; Markwell et al. 2010; Maynard et al. 
2015). Two recent studies observed that sleep duration was altered in advanced AMD 
patients; sleep duration decreased in wet AMD and increased in dry AMD (Khurana et 
al. 2016; Pérez-Canales et al. 2016) but the effect of aberrant ipRGC signalling in 
AMD (Feigl & Zele 2014; Maynard et al. 2015) as a contributing factor was not 
evaluated. Supporting evidence for an association between ipRGC dysfunction and 
sleep disorders is provided in primary open angle glaucoma patients (Feigl et al. 
2011b; Kankipati et al. 2011) where there is also decreased sleep quality (Gracitelli et 
al. 2016; Gracitelli et al. 2015).  
 
IpRGCs project to brain areas implicated in mood regulation (LeGates et al. 2012) and 
patients with seasonal affective disorder (SAD) have a dysfunctional melanopsin 
mediated PIPR (Roecklein et al. 2013), indicative of a role of aberrant ipRGC 
signalling in the presence of SAD. In mouse models, depression related behaviour in 
wild type mice is observed in response to an altered light and dark cycle but not in 
ipRGC deficient mice (LeGates et al. 2012), demonstrating the ability of light 
signalling via ipRGCs to influence mood. Given that the melanopsin mediated PIPR is 
affected in early and late AMD (Feigl & Zele 2014; Maynard et al. 2015) and the 
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prevalence of depression in AMD patients is as high as 39% (Brody et al. 2001; 
Casten & Rovner 2013; Mitchell & Bradley 2006; Popescu et al. 2012), with its origin 
likely to be multifactorial (Casten & Rovner 2008), we determined the role that ipRGC 
dysfunction in AMD patients has in depression. Based on this evidence, the study aim 
is to investigate whether ipRGC dysfunction in AMD is correlated with sleep and 
mood disorders in patients with advanced stages of this condition. Here we measure 
melanopsin function using the post-illumination pupil response, and sleep and mood 
with validated questionnaires to assess non-visual behavioural disorders in the AMD 
patients. 
 
 METHODS 6.4
6.4.1 Participants 
Seventy-three participants (41 female, 32 male) were recruited from the 
Queensland Eye Institute (QEI), Queensland University of Technology (QUT) eye 
clinic and local optometry practices. Table 6.1 provides a summary of the participant’s 
clinical characteristics. Forty six of these participants had advanced neovascular AMD 
(CNV) (AREDS grade 4) (Age-Related Eye Disease Study Research Group 2001b) 
and were under treatment with anti-vascular endothelial growth factor (Lucentis
®
 or 
Eylea
®
). Seven participants had advanced geographic atrophy (GA; AREDS grade 4) 
and twenty participants served as healthy controls. The age range of the healthy 
controls is lower than that of the AMD patients (Table 6.1); however, this age 
difference was not statistically significant. All participants underwent an ophthalmic 
examination that included visual acuity, ophthalmoscopy, intraocular pressure 
measurement and optical coherence topography (OCT, Cirrus HD-OCT; Carl Zeiss 
Meditec, Inc. Dublin, CA, USA). Although 36 participants had intraocular lens (IOL) 
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implants, all participants had normal iris musculature post-surgery and cataract 
removal surgery does not adversely affect circadian rhythm or sleep (Brondsted et al. 
2015), with no difference in blue light transmission between blue-blocking and neutral 
IOLs (Alexander et al. 2014; Brondsted et al. 2015). Those participants without IOLs 
(AMD, n = 21; control, n = 16) had crystalline lens opacities < Grade 2 (LOCS III) 
(Chylack et al. 1993), thus limiting the effect of blue light attenuation by the ageing 
lens (Kessel, Lundeman, Herbst, Andersen & Larsen 2010). Clinical trials show that 
an average of 5.6 anti-VEGF injections is administered over 12 months in patients 
suffering from neovascular AMD (Abedi, Wickremasinghe, Islam, Inglis & Guymer 
2014; Fung et al. 2007; Lalwani et al. 2009). This is in accordance with the treatment 
frequency in our cohort of 5.8 injections per year; therefore, the number of injections 
administered was grouped in increments of six for comparison of the treatment effect 
within a 12 month period (Table 6.1). Five out of 53 patients were taking anti-
depressant medication (Zoloft
®
, Lumin
™
 or Lexam
™
) that could affect the pupil 
response and this was considered in the statistical analysis. There was no history of 
ocular disease or medication affecting the pupil in the control participants. The AMD 
patients had no ocular disease other than AMD. Written informed consent was 
obtained from all participants and the study was conducted in accordance with the 
requirements of the Queensland University of Technology Human Research Ethics 
Committee and the tenets of the Declaration of Helsinki. 
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Table 6.1: Summary of AMD patient and control participant distribution based on their 
clinical characteristics. 
  CNV GA Control 
Number of participants n = 46 n = 7 n = 20 
Age (years) 78.4 ± 8.7 80.7 ± 9.7  72.5 ± 3.3 
Gender 16 M; 30 F 4 M; 3 F 12 M; 8 F 
IOL n = 28 n = 4 n = 4 
VA (Snellen)                6/6 - 6/12 n = 22 n = 0 n = 20 
6/15 - 6/36 n = 17 n = 4 n = 0 
6/48 - CF n = 7 n = 3 n = 0 
Number of injections            0 - 6 n = 11 - - 
                       7-12 n = 6 - - 
13-18 n = 6 - - 
19-24 n = 8 - - 
25-30 n = 5 - - 
31-36 n = 6 - - 
37-50 n = 4 - - 
GA: Geographic atrophy; CNV: Choroidal neovascularization; IOL: Intraocular lens 
VA: Visual acuity; CF: Counting fingers 
 
6.4.2 Assessment of sleep and depression 
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) 
questionnaire (Buysse et al. 1989), a self-assessed screening tool that has been used to 
determine sleep disturbances in glaucoma (Ayaki et al. 2016; Wang et al. 2013) and to 
assess sleep quality prior to measurement of the circadian response of ipRGCs (Zele et 
al. 2011). The PSQI is primarily designed to measure sleep based on a global score. 
Presence and risk of depression was determined using the Centre for Epidemiologic 
Studies Depression Scale (CES-D) (Radloff 1977), a self-report test designed to 
measure symptoms associated with depression. The twenty item CES-D questionnaire 
comprises six scales reflecting the major facets of depression: depressed mood, 
feelings of guilt and worthlessness, feelings of helplessness and hopelessness, 
psychomotor retardation, loss of appetite, and sleep disturbance. These symptoms 
have been used in previously validated scales and the CES-D has high test-retest 
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reliability and internal consistency (Radloff 1977). The Seasonal Pattern Assessment 
Questionnaire (SPAQ) (Rosenthal, Genhardt, Sack, Skwerer & Wehr 1987) was used 
to screen for the presence of Seasonal Affective Disorder (SAD) and provided insight 
into factors such as social activity, weight, appetite and energy that may influence 
mood. While the SPAQ has high specificity, it has low sensitivity and was therefore 
used for screening rather than as a diagnostic instrument (Mersch et al. 2004).    
 
6.4.3 Pupillometry 
To assess ipRGC function we measured the melanopsin mediated PIPR using 
customized paradigms developed in our laboratory (Adhikari, Pearson, Anderson, Zele 
& Feigl 2015a; Adhikari et al. 2015b; Feigl et al. 2011b; Feigl & Zele 2014; Maynard 
et al. 2015) with high irradiance stimuli designed for use with the RAPDx 
pupillographer (Konan Medical USA, Inc., Irvine, CA). IpRGCs produce a sustained 
pupil constriction after offset of short wavelength light known as the post-illumination 
pupil response (PIPR) (Gamlin et al. 2007; Kawasaki & Kardon 2007; Markwell et al. 
2010), which is absent with presentation of long-wavelength stimuli that have low 
melanopsin excitation. IpRGCs also receive extrinsic signals from rods and cones 
(Altimus et al. 2010; Altimus et al. 2008; Perez-Leon, Warren, Allen, Robinson & 
Lane Brown 2006), which can be measured by the initial pupil constriction amplitude 
(McDougal & Gamlin 2010). Monocular red and blue light stimuli were presented in 
Newtonian view on a liquid crystal display (LCD) with a 40 Hz frame rate, with a 
central physical barrier creating two optical channels for recording binocular pupil 
responses under infrared illumination. The screen was viewed at infinity through a pair 
of 50-mm objective lenses to produce a 25° field of view in each eye. Monochromatic 
stimuli included a 10 s pulse of blue light (short wavelength, λmax = 448 nm, corneal 
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irradiance: 14.5 log quanta.cm
−2
.s
−1
, luminance: 1.3 log cd.m
−2
) and red light (long 
wavelength, λmax = 604 nm, corneal irradiance: 14.4 log quanta.cm
−2
.s
−1
, luminance: 
1.0 log cd.m
−2
). The spectral outputs of the LED stimuli were measured with a 
Spectroradiometer (StellarNet, Florida, USA) and irradiance and luminance was 
measured with an ILT1700 Research Radiometer (International Light Technologies, 
Massachusetts, USA). A target (green cross) was used for patient fixation. A display 
screen mounted on the side of the RAPDx allowed the examiner to monitor patient 
fixation during testing. 
 
6.4.4 Procedure 
Where AMD was present in both eyes, the worse eye was dilated with 1% 
Tropicamide (Alcon Laboratories, NSW, Australia), and the preferential eye was 
dilated in healthy controls. The consensual PLR was measured. Participants were 
adapted to the dim room illumination (< 1 lux) for 10 minutes prior to testing. The 
pupil testing started with a further 10 s dark adaptation before recording. Baseline 
pupil diameter was then measured during 5 s of fixation prior to onset of the 10 s 
stimulus and the post-stimulus response was recorded for 40 s. This resulted in a 55 s 
interstimulus interval between the long and short wavelengths stimulus. 
Questionnaires were administered while the patients’ eye was dilating. All testing 
occurred between 8 AM and 4 PM to minimize the effect of circadian variation on 
the PIPR amplitude (Münch, Léon, Crippa & Kawasaki 2012; Zele et al. 2011). 
 
6.4.5 Data Analysis 
The PSQI comprises seven components that are each scored on a Likert scale from 0 
to 3 and then summed to provide a global score, with higher scores indicating poorer 
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sleep quality (Buysse et al. 1989). While global scores provide an indication of overall 
sleep quality, factor analysis has since shown that a multiple factor model is 
statistically favoured over a global score (Cole et al. 2006; Magee et al. 2008), 
therefore we scored and analysed the PSQI using sleep quality and sleep efficiency 
components (Magee et al. 2008). Sleep quality included scores from the subjective 
sleep quality, sleep latency and sleep disturbance components, while sleep efficiency 
included scores from sleep duration and calculated sleep efficiency components (time 
in bed vs time asleep). Sleep factor scores were calculated by multiplying the 
component score by the factor loading given by Magee et al (2008) and summing 
them.  
 
The CES-D questionnaire is also scored on a Likert scale from 0 to 3 with higher 
scores indicating more depression symptoms, weighted by frequency of occurrence 
during the past week (Radloff 1977). A cut-off score of 16 aids in identifying people at 
risk for clinical depression. Using continuous scoring criteria as described by Radloff 
(1977), patients were identified as having no clinically significant depression 
symptoms, sub-threshold depression symptoms, possible or probable major depressive 
symptoms or having met major depressive episode criteria. Where depressive 
symptoms were a concern, the treating ophthalmologist for the AMD patients was 
informed, and control participants were advised to see a general practitioner. The 
SPAQ measures seasonal variations in six items (mood, appetite, weight, sleep, energy 
and socializing) by scoring each item on a 5-point scale ranging from 0 (no change) to 
4 (marked change). The global score (range 0 – 24) was calculated by adding the 
individual item scores and a score ≥ 11 identified the presence of SAD (Kasper, Wehr, 
Bartko, Gaist & Rosenthal 1989).  
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Pupil analysis included identification and extraction of blink artefacts during analysis 
of pupil recordings by a customized software algorithm with linear interpolation 
(Adhikari et al. 2015b). The data were fitted with linear and exponential models (Feigl 
& Zele 2014; Zele et al. 2011) and analyzed according to our established protocols 
(Adhikari et al. 2015b). To control for individual differences in resting pupil diameter, 
all data are reported as a percentage of the resting baseline pupil diameter (average 
pupil diameter during 5 s pre-stimulus period) (Adhikari et al. 2015a; Adhikari et al. 
2015b); a larger percentage value indicates smaller constriction amplitude. The PIPR 
was quantified at six seconds after light stimulus offset (Park et al. 2011). Initial pupil 
constriction was defined as the minimum pupil diameter within three seconds after 
stimulus onset (Kostic et al. 2016; Thompson et al. 2011). The short wavelength 
stimulus with high melanopsin excitation (609.8 α-opic lux) served to measure the 
intrinsic ipRGC response. The long wavelength stimulus with low melanopsin 
excitation (9.7 α-opic lux) was presented as the control and to account for autonomic 
pupillary reactivity and is not reported. 
 
6.4.6 Statistical Analysis 
Statistical analyses were performed using commercially available statistical 
software (IBM SPSS, version 21; IBM Corporation, Armonk, NY, USA). Normality 
was assessed using the Shapiro-Wilk test. Independent samples t-tests evaluated each 
variable (presence of IOL, initial constriction, PIPR, sleep quality, sleep efficiency and 
level of depression) between the CNV and geographic atrophy patients, as well as 
between the control group and AMD group. Spearman’s correlation coefficient was 
used to determine the association between the pupil metrics (initial constriction and 
PIPR) and sleep (global score, sleep quality and sleep efficiency), as well as between 
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the pupil metrics and depression scores within the AMD group. These analyses were 
repeated after excluding the five patients who were taking anti-depressant medication. 
The association between visual acuity and number of injections administered with 
depression and sleep scores was determined using correlation analysis. Where a 
significant correlation was found, linear regression analysed the relationship between 
sleep and depression scores and the pupil metrics. A p-value of < 0.05 was considered 
statistically significant. 
 
 RESULTS 6.5
There was no significant difference between the CNV (n = 46) and GA (n = 7) 
patients for initial pupil constriction amplitude, PIPR amplitude, depression score and 
global sleep score, therefore AMD patient’s with CNV and GA were combined into a 
single group for additional analyses. There was no significant effect of IOL surgery on 
all parameters. Multiple regression analysis showed no effect of age (β = 0.14, p = 
0.07, R
2
 =0.05); IOL (β = -1.8, p = 0.13, R2 =0.03); and treatment frequency (β = -0.2, 
p = 0.16, R
2
 =0.08) on the PIPR. The mean (± standard deviation) values of all 
measured variables (pupil parameters, sleep and mood scores) for the AMD group and 
control group are given in Table 6.2. The long wavelength stimulus showed a low 
variability (± 3.3%), indicative of a minimal effect of autonomic reactivity. The pupil 
parameters (pupil constriction and PIPR) for the AMD group were significantly 
reduced compared to the control group indicating lesser pupil constriction amplitudes 
at stimulus onset and at post-illumination. The AMD group had a higher global sleep 
score indicating poorer sleep compared to controls. Analysis of the sleep factor 
components demonstrated sleep efficiency scores were higher in the AMD group 
however; the sleep quality score was not significantly different between groups. The 
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AMD group had a significantly higher level of depression compared to the control 
group (Table 6.2). All participants scored less than 4 on the SPAQ index with the 
exception of one AMD patient who scored 8 out of a possible 24 and was still below 
the cut-off for seasonal affective disorder. 
 
Table 6.2: Mean (± standard deviation) values for the pupil parameters, sleep component 
and depression scores for AMD patients and healthy control participants. 
 AMD Participants Control Participants p value 
 (n=53) (n=20)  
Initial constriction 
amplitude (% baseline) 
65.7 ± 8.0 61.5 ± 6.9 0.039* 
PIPR amplitude  
(% baseline) 
91.2 ± 5.9 87.4 ± 4.0 0.003* 
PSQI Global Score 6.5 ± 3.2 4.5 ± 2.5 0.013* 
Sleep Quality Score 2.6 ± 1.7 1.9 ± 1.2 0.057 
Sleep Efficiency Score 1.5 ± 1.1 0.8 ± 0.5 0.001* 
CES-D Score 9.3 ± 9.1 2.9 ± 4.0 < 0.001* 
* p < 0.05 
 
 
Correlation analyses identified a positive correlation between the PIPR amplitude and 
global sleep score (r = 0.34, p = 0.01) for the AMD group (Figure 6.1A). As the PIPR 
amplitude increased, indicating a reduced sustained constriction, the global score 
increased demonstrating poorer sleep behaviour (F1,51 = 6.75, p = 0.01, R
2 
= 0.12). 
Correlations between the PIPR amplitude and sleep efficiency and sleep quality 
factors in the AMD group identified that poorer sleep efficiency was associated with a 
decrease in PIPR amplitude (r = 0.36, p = 0.01) (regression; F1,51 = 7.55, p = 0.01, R
2
 = 
0.13) (Figure 6.1C) but no correlation was found between sleep quality and PIPR (r = 
0.17, p = 0.23) (Figure 6.1E). Initial pupil constriction amplitude did not correlate with 
the global sleep score (r = 0.09, p = 0.52), sleep efficiency (r = 0.12, p = 0.41) or sleep 
quality (r = 0.05, p = 0.71) in the AMD group. Sleep scores (CNV and GA group) did 
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not correlate with visual acuity (r = -0.04, p = 0.77) or number of injections 
administered in the CNV group (r = 0.19, p = 0.19). 
 
For the depression score analysis, 2/53 AMD patients met the criteria for major 
depression, 2/53AMD patients had possible major depression and 6/53 AMD patients 
had symptoms of subthreshold depression. Five AMD patients were taking anti-
depression medication; one control participant had subthreshold depression symptoms 
while all other control participants showed no clinical signs of depression. There was 
no correlation between the PIPR and depression score for the AMD group (r = 0.23, p 
= 0.1) (Figure 6.2A). The AMD patients (n = 4) with major or possible major 
depression according to the CES-D scores did not have significantly reduced PIPR 
amplitudes compared to the mean PIPR for the AMD group. Exclusion of the patients 
on anti-depressant medication did not affect the average pupil measurements. There 
was no correlation between depression scores and the initial pupil constriction 
amplitude (p > 0.05). Depression scores did not correlate with visual acuity in the 
CNV/GA group (r = 0.03, p = 0.85) or number of injections administered in the CNV 
group (r = 0.13, p = 0.38). 
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Figure 6.1: Correlation between PIPR and sleep components.  
The scatterplot and linear regression lines show the association between the 6s PIPR to a blue 
light stimulus (λmax = 448 nm) and sleep components in AMD patients (n = 53) and healthy 
control participants (n = 20). The horizontal line in the top graphs indicates a cut-off point in 
the global score to distinguish between ‘good’ (< 5) and ‘poor’ (> 5) sleep. 
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Figure 6.2: Correlation between PIPR and mood.  
The scatterplot and linear regression lines show the association between the 6s PIPR to a blue 
light stimulus (λmax = 448 nm) and depression in AMD patients (n = 48) and healthy control 
participants (n = 20). The horizontal line indicates a cut-off point to identify people at risk for 
depression (> 16) and those with low to no risk for depression (< 16). 
 
 
 DISCUSSION 6.6
This is the first study to investigate the relationship between intrinsically 
photosensitive retinal ganglion cell (ipRGC) function, sleep behaviour and depression 
in advanced age-related macular degeneration (AMD). Our hypothesis was that altered 
ipRGC function in AMD will lead to sleep and mood disturbances due to their 
projections to corresponding brain areas. Based on previous studies (Gracitelli et al. 
2015; LeGates et al. 2012), we proposed that aberrant light signalling through 
dysfunctional ipRGCs will contribute to these behavioural changes. A positive 
correlation was observed between reduced ipRGC function as measured by the 
melanopsin mediated post-illumination pupil response (PIPR) and poorer sleep 
efficiency, with ipRGC dysfunction accounting for 13% of the reduced sleep 
efficiency. There was no relationship between ipRGC function and risk of depression 
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in AMD patients, however, a limitation of this study is that the number of depressed 
AMD patients was low, hence further studies with a larger cohort are needed. 
 
All three photoreceptor types; rods, cones and ipRGCs are affected in advanced AMD 
(Curcio et al. 1996; Maynard et al. 2015) and contribute to the initial pupil constriction 
during stimulus presentation (McDougal & Gamlin 2010) whereas ipRGCs and rods 
contribute to the sustained post-illumination pupil response (Adhikari et al. 2016a; 
Gamlin et al. 2007). At least five different ipRGC subtypes (M1–M5) (Ecker et al. 
2010; Schmidt et al. 2011a) have been identified that project to non-image forming 
centres in the rodent brain, with the M1 and M2 subtypes likely to be homologous to 
the outer and inner stratifying melanopsin cells found in humans and non-human 
primates (Dacey et al. 2005; Jusuf et al. 2007; Liao et al. 2016). A recent mouse study 
using single M1 ipRGC axonal tracing and confocal microscopic analysis identified up 
to five different brain targets that received input from a single M1 subtype ipRGC, 
indicating that a single ipRGC can affect brain areas involved in numerous light-
mediated behaviours (Fernandez, Chang, Hattar & Chen 2016). Therefore, the 
correlation between poorer sleep efficiency and reduced PIPR may be attributed to 
individual M1 ipRGCs projecting to both the SCN and OPN. 
   
Poor sleep is a common complaint in the aged population (Mant & Eyland 1988) but 
there is no evidence for a significant age-related difference in sleep behaviour (Foley, 
Ancoli-Israel, Britz & Walsh 2004; Hoch, Dew, Reynolds & Monk 1994), consistent 
with data from our healthy control group, suggesting that the sleep problems detected 
in the AMD group are secondary to comorbidities rather than to ageing (Foley et al. 
2004). Furthermore, ipRGC function is robust to ageing (Adhikari et al. 2015a; 
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Kankipati et al. 2010), with one study showing an enhanced response to high 
irradiance short wavelength light associated with advancing age (Herbst et al. 2012). 
Therefore it is unlikely that the advanced age of the participants provided the basis for 
the association between ipRGC dysfunction and poor sleep efficiency in this study. 
Other contributors to poor sleep behaviour in the elderly may include changes relating 
to time in REM and slow-wave sleep (Stanley 2005), medical or psychiatric illness 
(Foley et al. 2004) and sleep-related disorders such as restless legs syndrome or sleep 
apnoea (Ancoli-Israel & Ayalon 2006; Keenan, Goldacre & Goldacre 2016), although 
only sleep apnoea has been previously associated with AMD (Keenan et al. 2016). The 
sleep quality component of the PSQI questionnaire considers these contributing factors 
as it addresses sleep disturbances and perceived sleep quality, however these were 
non-significant in our cohort.   
 
Depression in AMD has been attributed to functional disabilities and loss of 
independence due to impaired vision (Brody et al. 2001; Casten & Rovner 2013; Jivraj 
et al. 2013; Nollett et al. 2016; Popescu et al. 2012; Varano et al. 2016). Of the AMD 
patients in this study, 28% had either met criteria for risk of depression or were taking 
anti-depressant medication. However no correlation between ipRGC function and 
depression in advanced AMD was found; hence our hypothesis for a causal 
relationship between these cells’ dysfunction and altered signalling to mood centres 
could not be evaluated in this sample. Irregular light exposure can influence cognitive 
and mood functions directly through ipRGCs (LeGates et al. 2012) as demonstrated in 
patients with SAD who have a reduced PIPR amplitude (Roecklein et al. 2013). SAD 
may be caused by an abnormal response to seasonal light changes (Bunney & Bunney 
2000) with melanopsin gene variants increasing the risk for SAD in 5% of individuals 
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(Roecklein et al. 2009). As the SAD patients had no ocular pathology, the lower PIPR 
amplitude may be due to irregular light exposure, although this was not measured in 
that study (Roecklein et al. 2013). Our AMD cohort did not report any symptoms of 
SAD; therefore the reduced PIPR amplitude in our study may be due to pathological 
ipRGC dysfunction that leads to aberrant inputs to the brain, rather than due to 
irregular light exposure. It is still unknown which ipRGC subtype(s) project to mood 
centres in the human brain and whether these projections are affected by AMD. Visual 
acuity and number of intravitreal injections did not correlate with the depression 
scores in this study. Visual impairment is a risk factor for depression but it is not an 
inevitable consequence of vision loss and depression can occur regardless of the level 
of vision impairment (Brody et al. 2001; Rees et al. 2010). Further research is needed 
to determine the cause of the association between AMD and depression.  
    
In conclusion, this study provides the first evidence that ipRGC dysfunction 
contributes to reduced sleep efficiency in patients with advanced AMD. With subtypes 
of melanopsin ipRGCs that stratify in different regions of the inner plexiform layer 
and project differentially to the SCN and OPN, this new knowledge advances insights 
into ipRGC contributions to AMD and its non-vision related disorders, allowing a 
further understanding of this complex condition.     
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 Discussion Chapter 7:
 SUMMARY OF RESULTS 7.1
This thesis developed novel mesopic techniques to improve the detection of early 
age-related macular degeneration (AMD). The role of intrinsically photosensitive 
retinal ganglion cells (ipRGCs) as a new biomarker of disease was determined in 
early AMD. The effect of outer and inner retinal dysfunction as a consequence of 
advanced AMD on non-visual functions such as sleep and depression was 
investigated. Pupillometry was identified as a reliable tool for detecting early AMD 
and for detecting reduced sleep efficiency in advanced AMD. These findings have 
potential clinical implications allowing for implementation of lifestyle changes at an 
early stage of the disease and for bringing awareness to a treatable, non-visual, 
behavioural burden in AMD that is impaired sleep. 
 
The first experiment (Chapter 4) developed new protocols for use with clinically 
available instruments (Pelli-Robson contrast sensitivity chart and MP-1 
microperimeter) under reduced (mesopic) illumination to measure retinal function 
under conditions where both rods and cones are active (Zele & Cao 2015; Zele et al. 
2013). The hypothesis was that mesopic contrast sensitivity can detect functional 
deficits before photopic tests in early and intermediate AMD. Although mesopic 
light level testing in ageing and disease has been explored previously (Bi, Gillespie-
Gallery, Binns & Barbur 2016; Gillespie-Gallery, Konstantakopoulou, Harlow & 
Barbur 2013; Pesudovs, Marsack, Donnelly, Thibos & Applegate 2004; Puell et al. 
2012; Puell et al. 2004; Sunness et al. 2008), utilising the testing methods described 
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in those studies in clinical practice is not feasible as most are specialised for research 
or are not clinically available. This experiment verified the hypothesis in part by 
demonstrating that administering the Pelli-Robson CS test under mesopic 
illumination can detect significant reductions in retinal function in early stages of 
AMD that are not detected under photopic test conditions and that can be 
differentiated from normal ageing. This increased sensitivity to retinal deficits in 
AMD provides the clinically feasible means for detecting and monitoring disease 
progression through comparison of mesopic results with normal values. No further 
improvement in the sensitivity of the MP-1 microperimeter between the standard 
(high mesopic) and lower mesopic test conditions was found, confirming the already 
high sensitivity of microperimetry in detecting early stages of disease. Although no 
marked difference was seen in macular sensitivity between the different AMD risk 
genotypes under low mesopic illumination, only one patient had the high risk gene 
variants for both CFH and ARMS2 and this person showed decreased MP-1 macular 
sensitivity. Further research in a larger cohort of patients with the combined high risk 
genotypes is required to determine if low mesopic microperimetry can detect a 
persons’ genetic risk of developing AMD.  
    
The second experiment (Chapter 5) used pupillometry to measure a recently 
discovered photoreceptor population; the intrinsically photosensitive retinal ganglion 
cells (ipRGCs). Given that there is rod and cone photoreceptor loss in early AMD, 
the role of ipRGCs in early detection of AMD was considered. Here it was 
hypothesized that persons with early stages of AMD would show reduction of inner 
(ipRGC) retinal function compared to healthy age-matched controls. The findings in 
Experiment 2 (Chapter 5) supported this hypothesis and this was the first study to 
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identify ipRGC dysfunction in early and intermediate stages of AMD through 
measurement of the melanopsin mediated post-illumination pupil response (PIPR). 
The pupil light reflex (PLR) also provided information on rod and cone function as 
the initial constriction at stimulus onset is primarily outer retina driven with ipRGC 
contribution increasing with stimulus duration (Güler et al. 2008; Lucas et al. 2003). 
The phase amplitude percentage metric (PAP) (Feigl & Zele 2014) was also reduced 
in early AMD compared to healthy controls, providing an additional means to 
identify onset of altered inner and outer retinal interactions (see Section 5.6). These 
findings demonstrate a higher vulnerability to AMD pathomechanisms as opposed to 
those diseases affecting the peripheral retina or optic nerve and this is discussed later 
in the chapter. 
 
Given melanopsin expressing ipRGCs are affected in all stages of AMD (Feigl & 
Zele 2014; Maynard et al. 2015) and they project to brain centres with both image-
forming and non-image forming functions, experiment 3 (Chapter 6) investigated 
how ipRGC dysfunction in AMD impacts on sleep and mood centres where they 
have main projections. The hypothesis was that persons with reduced ipRGC 
function will have poorer sleep and increased depression scores compared to persons 
with normal ipRGC function. The hypothesis was supported in part with findings that 
demonstrated that ipRGC dysfunction correlated with reduced sleep efficiency in 
AMD, whereas no relationship was found between depression and ipRGC function. 
This study provides the first evidence that ipRGC dysfunction is associated with 
reduced sleep efficiency in patients with advanced AMD (see Section 6.5), 
supporting a retinal origin contributing to sleep disorders in AMD together with 
multifactorial causes.  
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This thesis proposes new clinical techniques for determining retinal function in 
AMD. The diagnostic accuracy of these techniques has been determined and a new 
clinical protocol is recommended. In addition to the new clinical techniques, the 
results of this thesis provide further insight into the effects of AMD on inner retinal 
function which will be discussed in the following.     
 
 EFFECTS OF EARLY AMD ON INNER RETINAL FUNCTION 7.2
Although AMD is a multifactorial disease, ischemia has been proposed as a major 
trigger for AMD, brought about by abnormalities in choroidal and retinal blood flow 
(for review, see Feigl 2009). The inner retina is supplied by two vascular networks; a 
superficial capillary network within the nerve fibre layer and a deep network 
between inner nuclear layer and outer plexiform layer, while the avascular foveal 
region is supplied by outer retina choroidal circulation (Hayreh 1990). Between the 
retinal and choroidal circulation lies a watershed zone, an area of relatively poor 
vascularity between two or more end-arteries which is vulnerable to ischemia 
(Hayreh 1990). Evidence suggests that the macular choroid is particularly vulnerable 
to ischaemia due to the number of watershed zones that meet there (Hayreh 1974, 
1983; Kornzweig 1977). Feigl et al (2007a) proposed that post-receptoral neurons 
which are located in the watershed zone may be more vulnerable to ischemia, 
whereas the photoreceptors may be more resistant to ischemic insult due to their 
proximity to metabolic reserves in the RPE and the choriocapillaris (Cringle, Yu, Yu 
& Su 2002). This hypothesis is supported by histopathological findings showing that 
when the RPE degenerates, the post-receptoral outer plexiform and inner nuclear 
layers are first affected (Sarks et al. 1988).  
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The inner plexiform layer (IPL) is a vascular watershed between the choroidal and 
retinal circulation (Alder & Cringle 1990) and has been identified in animal models 
as a dominant oxygen consumer (Yu & Cringle 2001). IpRGCs have the largest 
identified retinal ganglion cell dendritic fields (Dacey et al. 2005) and dendrites are 
considered the major energy consumers of the nervous system (Wong-Riley 1989). 
Further, the IPL is the retinal layer where ipRGC dendrites stratify (Dacey et al. 
2005), therefore in the presence of ischemia, a driving role for AMD (Feigl 2007; 
Grunwald et al. 2005; Pemp & Schmetterer 2008), the melanopsin expressing 
dendrites may be first affected before outer retinal dysfunction is detected. As 
dendrites play a critical role in integrating synaptic inputs and in determining the 
extent to which action potentials are produced by the neuron (Urbanska, Blazejczyk 
& Jaworski 2008), if the dendrites are affected by ischemia, then a dysfunction will 
be seen early in the disease even if the cell bodies, located in the ganglion cell layer, 
are initially unaffected. 
 
While ipRGC loss due to its location in the watershed zone may be one cause of 
early deficits in AMD, ipRGC dysfunction may also be due to retinal pigment 
epithelium (RPE) defects that are associated with the initiation and progression of 
AMD. Arden et al (2005) proposed that ischaemia in AMD is driven by the high 
oxygen demand of the rods that cannot be met due to altered RPE function. Whether 
RPE dysfunction is a consequence of reduced choroidal blood flow in AMD remains 
to be determined (Feigl et al. 2007a). A functional RPE is required to maintain 
retinal health and synthesize 11-cis-retinal through the retinoid cycle (Baehr, Wu, 
Bird & Palczewski 2003). Deterioration of the RPE leads to thickening of Bruch’s 
membrane and lipid deposits which impede normal diffusion of waste products and 
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nutrients between the choroid and retina and may further impair the transport of 
metabolites of the retinoid cycle (Curcio 2001). Although ipRGCs have an intrinsic 
ability to regenerate melanopsin under low light levels (Tu et al. 2006), during 
prolonged and high illumination conditions, melanopsin regeneration depends partly 
on 11-cis-retinal from the RPE, possibly imported via Müller cells (Zhao, Pack, 
Khan & Wong 2016). Further, sodium iodate induced damage to the RPE in a rat 
model shows diminished markers of the dopaminergic system responsible for 
regulating melanopsin, as well as significantly reduced melanopsin expression (Tao 
et al. 2013). This infers a dependency of melanopsin regeneration on the RPE, which 
is affected in early AMD, and provides a possible pathway for the reduced inner 
retinal function that was initially thought to only be affected in late stages of the 
disease.  
 
 EFFECTS OF ADVANCED AMD ON INNER RETINAL FUNCTION 7.3
In a histopathological investigation of human retinal tissue, Medeiros and Curcio 
(2001) demonstrated a ~47% loss of retinal ganglion cells (RGCs) in advanced 
exudative AMD and claim that the number of surviving RGCs may be sufficient to 
support signal transmission to the brain. The majority of cell bodies of the ipRGCs 
are located in the ganglion cell layer, however, due to their low numbers (~3000 
cells) (Dacey et al. 2005), even a small loss of these cells could cause noticeable 
functional deficits in advanced AMD. A combination of dysfunctional melanopsin 
expressing dendrites and loss of ipRGC cell bodies may explain the significantly 
reduced PIPR in advanced AMD seen in this study (Chapter 6). IpRGCs project to 
target brain centres, including to the suprachiasmatic nucleus (SCN) for 
photoentrainment (Chen et al. 2011), the ventrolateral preoptic (VLPO) area to 
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mediate sleep induction (Gooley et al. 2003; Hattar et al. 2002), the olivary pretectal 
nucleus (OPN) for pupil mediation and to brain areas implicated in mood (LeGates et 
al. 2012). Quality of sleep is poor (Keenan et al. 2016; Pérez-Canales et al. 2016) and 
there is a high prevalence of depression in advanced AMD patients (Brody et al. 
2001; Casten & Rovner 2013; Nollett et al. 2016; Rovner & Casten 2002), however 
the association of dysfunctional ipRGCs with poor sleep and depression in AMD had 
not been previously investigated.  
 
Circadian photoentrainment and pupil constriction have mixed rod/cone and ipRGC 
input (Hattar et al. 2003; Lucas et al. 2001a; Lucas et al. 2003) with rod-cone input 
primarily mediating short latency and dim light detection and melanopsin controlling 
longer latency and bright light responses (Lupi, Oster, Thompson & Foster 2008; 
Peirson & Foster 2006). Further; rods, cones and ipRGCs are all affected in advanced 
AMD (Curcio et al. 1996; Maynard et al. 2015) and contribute to the initial pupil 
constriction during stimulus presentation (McDougal & Gamlin 2010) and the 
sustained post-illumination pupil response (Adhikari et al. 2016a; Gamlin et al. 
2007). IpRGC subtypes M1 and M2 that have been identified in humans (see Section 
2.3.1) differentially innervate the SCN (80% M1 and 20% M2) and OPN (45% M1 
and 55% M2) (Baver, Pickard, Sollars & Pickard 2008), although pupillometry only 
measures the function of OPN-projecting ipRGCs. In a study of the golden hamster 
that examined ganglion cell bifurcations and projections using retrograde tracers, 
Morin et al (2003) showed that bifurcation may be a common feature among 
melanopsin expressing ganglion cells that likely project to many subcortical targets. 
A more recent mouse study using single M1 ipRGC axonal tracing and confocal 
microscopic analysis identified up to five different brain targets that received input 
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from a single M1 subtype ipRGC, indicating that a single retinal cell can affect brain 
areas involved in numerous light-mediated behaviours (Fernandez et al. 2016). 
Therefore, in conjunction with a validated measure of sleep, pupillometry may 
provide an indication of the severity of ipRGC dysfunction associated with poor 
sleep. The correlation between poor sleep efficiency and reduced PIPR demonstrated 
in this study supports this hypothesis. 
   
The effect of AMD on depression is more complex as ipRGC projections to mood 
centres in the brain include direct innervation of the medial amygdala, lateral 
habenula and subparaventricular zone which are involved in depression and anxiety, 
as well as indirect innervation through the suprachiasmatic nucleus of the ventral 
tegmental area and raphe which are involved in mood regulation (LeGates, 
Fernandez & Hattar 2014). This is shown in rodents in which at least five ipRGC 
subtypes have been identified, although only two subtypes are identified in humans. 
While ipRGC function is reduced in seasonal affective disorder (SAD) as measured 
using the PIPR (Roecklein et al. 2013), our study did not show a correlation between 
ipRGC function and depression in AMD. The following reasons have been 
considered. Seasonal affective disorder is characterized by depressive, hypo or hyper 
manic episodes recurring during certain seasons and is reactive to changes in 
environmental lighting (Rosenthal & Wehr 1987). The CES-D depression 
questionnaire used in our study was designed to measure depressive symptomology 
in the general population (Radloff 1977) and did not take into account long term light 
exposure. Further, non-seasonal depression is multifactorial and can be influenced by 
living conditions, family history and medical problems to name a few.      
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The effects of AMD extend beyond visual function, with poor sleep and high 
prevalence of depression associated with the disease (Augustin et al. 2007; Casten & 
Rovner 2008; Khurana et al. 2016; Pérez-Canales et al. 2016). This study showed a 
correlation between ipRGC function and sleep efficiency, therefore this thesis 
suggests that clinicians should consider using pupillometry along with screening 
sleep questionnaires when assessing the health and well-being of AMD patients.   
 
 DIAGNOSTIC ACCURACY OF MESOPIC VISION TESTS AND 7.4
PUPILLOMETRY 
To determine the best clinical test for detecting early AMD, the diagnostic 
accuracy of the mesopic vision tests and pupillometry was evaluated using receiver-
operating characteristic (ROC) curves. Figure 7.1 shows the ROC curves for the 
Pelli-Robson CS and MP-1 microperimetry tests under standard and mesopic 
illumination (see Section 3.1.2), and the post-illumination pupil response (PIPR) to 
short wavelength (blue) and long wavelength (red) light stimuli (see Section 3.2.2).  
 
Figure 7.1: Receiver operating characteristic curves 
The sensitivity (true positive rate) is plotted as a function of specificity (false positive rate) 
for Pelli-Robson CS (panel A), MP-1 microperimetry (panel B) and PIPR pupillometry 
(panel C) measurements. The mesopic conditions (black line) for CS and microperimetry 
(panels A and B) show higher sensitivity and specificity with a larger AUC compared to 
standard (grey line) testing conditions. The blue stimulus (blue line) PIPR measurement 
(panel C) shows a significantly higher sensitivity and specificity with the largest AUC 
compared to the mesopic tests.  
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Based on normal Pelli-Robson CS values for ages > 60 years (Mäntyjärvi & Laitinen 
2001), a selected cut-off of 1.28 log mesopic contrast provided a sensitivity of 90.5% 
(CI: 69.6% to 98.8%) and specificity of 56.5% (CI: 34.5% to 76.8%) with a positive 
likelihood ratio of 2.1 and an area under curve (AUC) of 0.78. Based on normal MP-
1 microperimetry values (Midena et al. 2010), a cut-off value of 18 dB provided a 
sensitivity of 64.7% (CI: 38.3% to 85.8%) and specificity of 66.7% (CI: 38.4% to 
88.2%) with a positive likelihood ratio of 1.9 and an area under curve (AUC) of 0.78 
while low mesopic microperimetry had comparative diagnostic accuracy with an 
AUC of 0.79 and positive likelihood ratio of 2.1. At a selected PIPR amplitude cut-
off of 69.1%, pupillometry provided a sensitivity of 95% (CI: 75.1% to 95.9%) and 
specificity of 80% (CI: 56.3% to 94.3%) with a positive likelihood ratio of 4.75 and 
AUC of 0.96. Both CS and microperimetry administered under low mesopic 
illumination have better diagnostic accuracy than under standard testing conditions 
while the pupillometry paradigms introduced in this study have excellent diagnostic 
accuracy and provide a rapid, non-invasive means of quantifying ipRGC function in 
early stages of AMD. As measurement of the PIPR is not affected by the disease 
status of the consensual eye, it provides the means to determine quantify ipRGC 
function in each eye.  
 
The value of introducing mesopic contrast sensitivity testing in clinical practice is 
clear as the change in testing conditions is as simple as reducing the room 
illumination which enhances detection of retinal deficits in early AMD. The benefit 
of pupillometry testing in clinical practice is that it not only provides excellent 
diagnostic accuracy of inner retinal ipRGC function, but also provides information 
on outer retinal rod and cone function, as well as inner and outer retinal interactions. 
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The protocol is rapid, objective, easily administered and does not require dilation 
when used in Maxwellian view (Adhikari et al. 2015b). 
 LIMITATIONS AND FUTURE DIRECTIONS 7.5
The mesopic light levels used in Experiment 1 were determined by the lowest 
levels that could be achieved using the available dimmer switch in the testing room, 
as well as by the retinal tracking of the fundus camera on the microperimeter. The 
difference between high and low mesopic microperimetry conditions was only 0.47 
cd.m
-2
. Studies that used the newer scotopic microperimeter (MP-1S) (Nebbioso et 
al. 2014; Steinberg et al. 2015) showed increased sensitivity to retinal dysfunction in 
AMD compared to standard mesopic microperimetry. In order to standardise testing 
protocols for use in clinical practice and determine the optimal light level required 
for maximum sensitivity, retinal function in AMD patients would need to be 
measured under a range of mesopic illuminations. Further, a normative database of 
patients with and without AMD would need to be established with which a clinician 
may compare a patients’ retinal function to determine the risk, onset and/or 
progression of AMD.  
 
In Experiment 2, full field pupillometry stimuli were used and while a significant 
reduction in retinal function was found, future testing with localised stimuli may 
provide further insight into the progression and location of the deficits, as well as 
identify patients at risk for AMD. In the final experiment, ipRGC function was 
measured using a commercial pupillometer (RAPDx) which has a blue stimulus with 
a shorter peak wavelength (448 nm) compared to melanopsin (482 nm) (Dacey et al. 
2005), broader spectral outputs and lower irradiance compared to the custom-built 
Maxwellian view pupillometer (see Section 5.4.2), therefore melanopsin activation 
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was not optimised. However, a significant difference in the PIPR between AMD 
patients and controls was still seen, validating the use of commercially available 
pupillometry to detect ipRGC dysfunction in AMD. Further, the use of sinusoidal 
stimuli in the custom-built pupillometer provided the means to measure inner and 
outer retinal interactions, therefore it would be beneficial to include these stimuli in 
the commercially available pupillometer. Finally, a larger number of patients are 
required to detect ipRGC dysfunction associations to depression. This is due to the 
multifactorial origin of the disease, as well as the extrinsic factors affecting its onset 
and progression; including environment, living arrangements, quality of life and 
access to support.  
Detection of retinal function deficits may permit diagnosis of disease progression 
before anatomic abnormalities become evident, allowing treatment intervention 
before irreversible retinal damage occurs. With the ongoing advances in AMD 
treatment, early diagnosis could further improve treatment outcomes. 
 
 CONCLUSION 7.6
This thesis provides the foundation on which to advance retinal function 
measurement in age-related macular degeneration (AMD). The use of a 
commercially available Pelli-Robson contrast sensitivity chart under mesopic light 
levels enhances the detection of retinal deficits in early and intermediate AMD while 
pupillometry provides a rapid, non-invasive means of quantifying ipRGC function in 
early stages of AMD through measurement of the post-illumination pupil response. 
This thesis further provides the first evidence that ipRGC dysfunction contributes to 
reduced sleep efficiency in patients with late AMD, advancing our knowledge on the 
relationship between AMD progression and non-vision related functions.  
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